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Chapter 1 
1 Literature Review 
 
 Introduction  
Cryptosporidium is an enteric protozoan parasite (phylum: Apicomplexa) that was first 
described in the gastric glands of laboratory mice in 1907 (Tyzzer, 1907). In 1976, 
Cryptosporidium was reported in an immune-suppressed adult (Meisel et al., 1976) and a 3-
year old child (Nime et al., 1976). Since then, Cryptosporidium infections have been reported 
in a wide variety of vertebrate hosts including reptiles, birds and fish, with symptoms and 
clinical signs ranging from asymptomatic to severe diarrhoea (Ryan et al., 2014; Zahedi et al., 
2016). In immunocompetent individuals, the infection is usually self-limiting (Ryan et al., 
2016a) but can cause prolonged and sometimes fatal infections in immunocompromised 
humans (Gerace et al., 2019). 
The Global Enteric Multicenter Study (GEMS), which began over a decade ago, identified 
Cryptosporidium as the second most important cause of moderate-to-severe diarrhoeal disease 
in children under 5-years of age in developing countries after rotavirus  (Kotloff et al., 2013; 
Levine et al., 2020). It also results in stunting and cognitive difficulties in young children 
(Kotloff et al., 2013; Sow et al., 2016). In developed nations including Australia, 
Cryptosporidium is the leading cause of recreational water-associated gastroenteritis 
outbreaks, with aquatic facilities a major contributor (Dale et al., 2010; Mayne et al., 2011; 
Waldron et al., 2011a; Ng-Hublin et al., 2015; Efstratiou et al., 2017; Cullinan et al., 2020). 
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In Australia, cryptosporidiosis is a notifiable disease via the National Notifiable Diseases 
Surveillance System (NNDSS). A combined effort from public health authorities, swimming 
pool users and managers of aquatic facilities are required to effectively prevent and control 
Cryptosporidium infections (Cullinan et al., 2020). However, despite the prominence of 
Cryptosporidium as a significant source of gastroenteritis in Australia and globally, relatively 
little is known about the epidemiology and risk factors of swimming pool-associated 
cryptosporidiosis outbreaks in Western Australia (WA). 
 Taxonomy 
Cryptosporidium species are apicomplexan parasites that predominantly infect the 
microvillus border of the gastrointestinal epithelium of a wide range of animals and humans 
(Xiao et al., 2004; Xiao, 2010). Until recently, Cryptosporidium was classified as a coccidian 
parasite, however, it has long been speculated that Cryptosporidium represents a ‘missing link’ 
between the more primitive gregarine parasites and coccidians (Ryan et al., 2016b). The 
similarities between Cryptosporidium and gregarines have been supported by extensive 
microscopic, molecular, genomic and biochemical data (Aldeyarbi and Karanis, 2016; Ryan et 
al., 2016b), which have served as the basis for the formal transfer of Cryptosporidium from 
subclass Coccidia, class Coccidiomorphea, to a new subclass, Cryptogregaria, within the 
gregarine parasite class Gregarinomorphea (Cavalier-Smith, 2014). In 2019, Adl et al. (2019) 
emended this to Cryptogregarinorida within Gregarinasina. However, more extensive genomic 
and transcriptomic analysis of Apicomplexan parasites suggest that Cryptosporidium 
represents a distinct lineage from gregarines (Mathur et al., 2019; Salomaki et al., 2021) and 
clearly a further taxonomic revision is required. 
Within the genus, the taxonomy of Cryptosporidium was initially based on morphological 
characteristics, infectious niches and assumed host-specificity. However, the lack of distinctive 
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morphological features to differentiate oocysts from different species and cross-transmission 
studies which demonstrated that isolates from different host species could be transmitted to 
one another, ended this practice (Fayer, 2010). The application of molecular characterisation 
tools has helped to clarify the confusion surrounding Cryptosporidium taxonomy and validated 
the existence of multiple species (Xiao, 2010; Zahedi et al., 2021). Currently, 46 
Cryptosporidium species are considered valid (Table 1.1) (Xiao and Feng, 2017; Zahedi et al., 
2021). In humans, more than 20 Cryptosporidium species and genotypes have been reported 




Table 1.1. Valid Cryptosporidium species confirmed by molecular analysis. 
Species name Reference Type host(s) Major host(s) Reports in 
humans  
C. myocastoris Ježková et al., 2021a Nutria 
(Myocastor coypus) 
Rodents None reported 
C. abrahamseni Zahedi et al., 2021 Red-eye tetra 
(Moenkhausia 
sanctaefilomenae) 
Fish None reported 
C. ratti Ježková et al., 2021b Brown rats (Rattus 
norvegicus) 
Rodents None reported 
C. bollandi Bolland et al., 2020 Angelfish (Pterophyllum 
scalare) and Oscar fish 
(Astronotus ocellatus) 
Fish None reported 
C. ornithophilus Holubová et al., 2020 Ostrich (Struthio 
camelus L.) 
Birds None reported 
C. proventriculi Holubová et al., 2019 Cockatiel (Nymphicus 
hollandicus) 
Birds None reported 
C. microti Horčičková et al., 2019 Common vole (Microtus 
arvalis) 
Rodents None reported 
C. alticolis Horčičková et al., 2019 Common vole (Microtus 
arvalis) 
Rodents None reported 









Lebbad et al., 
2021; Beser et 
al., 2020 
C. occultus Kváč et al., 2018 Brown rat (Rattus 
norvegicus) 
Rodents Xu et al., 2020; 
Robinson et 
al., 2011; Ong 
et al., 2002  
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Species name Reference Type host(s) Major host(s) Reports in 
humans  
C. homai Zahedi et al., 2017a Guinea pig (Cavia 
porcellus) 
Rodents None reported 



















C. avium Holubova et al., 2016 Red-crowned parakeet 
(Cyanoramphus 
novaezelandiae) 
Birds None reported 
C. proliferans Kváč et al., 2016 East African mole rat 
(Tachyoryctes splendes) 
Rodents None reported 
C. rubeyi Li et al., 2015 California ground 
squirrel (Spermophilus 
beecheyi) 
Squirrels None reported 
C. huwi Ryan et al., 2015 Guppy (Poecilia 
reticulata), Neon tetra 
(Paracheirodon innesi) 
and Tiger barb (Puntius 
tetrazona) 
Fish None reported 




Lebbad et al., 
2021; Garcia-R 
et al., 2020; 
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Species name Reference Type host(s) Major host(s) Reports in 
humans  
Kváč et al., 
2014b;  
C. scrofarum Kváč et al., 2013 Pig (Sus scrofa) Pigs  Kváč et al., 
2009b; Kváč et 
al., 2009a 
C. viatorum Elwin et al., 2012a Human (Homo sapiens) Humans Most reports in 
humans  
C. tyzzeri Tyzzer, 1912; Ren et al., 
2012  
Mouse (Mus musculus) Rodents Garcia-R et al., 
2020; Raskova 
et al., 2013; 
Sulaiman et al., 
2005;  
C. cuniculus Robinson et al., 2010 European rabbit 
(Oryctolagus cuniculus) 
Rabbits  Guy et al., 
2021; Lebbad 
et al., 2021; 
Garcia-R et al., 
2020; Lebbad 
et al., 2018; 
Martínez-Ruiz 
et al., 2016; 
Koehler et al., 
2014a; 
Puleston et al., 






al., 2011b;  











al., 2008;  





C. xiaoi Fayer et al., 2010 Sheep (Ovis aries) Sheep and goats Adamu et al., 
2014 
C. ryanae Fayer et al., 2008 Cattle (Bos taurus) Cattle None reported 
C. macropodum Power and Ryan, 2008 Kangaroo (Macropus 
giganteus) 
Marsupials None reported 
C. fragile Jirku et al., 2008 Toad (Duttaphrynus 
melanostictus) 
Toads None reported 
C. fayeri Ryan et al., 2008 Kangaroo (Macropus 
rufus) 
Marsupials Waldron et al., 
2011b; 
Waldron et al., 
2010 
C. bovis Fayer et al., 2005 Cattle (Bos taurus) Cattle Helmy et al., 
2013; Ng et al., 
2012;  Khan et 
al., 2010 




Turbot None reported 
C. suis Ryan et al., 2004 Pig (Sus scrofa) Pigs  Lebbad et al., 
2021; Sannella 
et al., 2019; 
Moore et al., 
2016; Bodager 
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Species name Reference Type host(s) Major host(s) Reports in 
humans  
et al., 2015; 
Wang et al., 
2013b; Cama 
et al., 2007; 
Leoni et al., 
2006; Xiao et 
al., 2002 




gallus, Tetrao urogallus, 
Pinicola enucleator) 
Birds None reported 
C. hominis Morgan-Ryan et al., 
2002 
Human (Homo sapiens) Humans Most common 
species in 
humans. 
C. molnari Alvarez-Pellitero and 
Sitja-Bobadilla, 2002 
Gilt-head sea bream 
(Sparus aurata) and 
European seabass 
(Dicentrarchus labrax) 
Fish None reported 
C. canis Fayer et al., 2001 Dog (Canis familiaris) Dogs Many reports  
C. andersoni Lindsay et al., 2000 Cattle (Bos taurus) Cattle Wu et al., 
2020; Hussain 
et al., 2017; 
Jiang et al., 
2014; Liu et 
al., 2014; 
Agholi et al., 
2013; Waldron 
et al., 2011a; 
Morse et al., 
2007; Leoni et 
al., 2006; 
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Species name Reference Type host(s) Major host(s) Reports in 
humans  
Guyot et al., 
2001 
C. varanii (syn. C. 
saurophilum)** 
Pavlasek et al., 1995 Emerald Monitor 
(Varanus prasinus) 
Lizards None reported 
C. baileyi Current et al., 1986 Chicken (Gallus gallus) Birds None reported 
C. serpentis Levine, 1980 Snakes (Elaphe guttata, 





C. felis Iseki, 1979 Cat (Felis catus) Cats Many reports 
C. wrairi Vetterling et al., 1971 Guinea pig (Cavia 
porcellus) 
Guinea pigs None reported 













C. muris Tyzzer, 1910 House mouse (Mus 
musculus) 
Rodents Many reports 
*Subsequent to the original description based on morphology and biology, GenBank accession numbers have 
been provided for 18S (KR340588) and actin (KR340589) sequences. 
**C. varanii takes precedence over C. saurophilum (Pavlasek and Ryan, 2008). 
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 Life cycle and biology 
The complex life cycle of Cryptosporidium includes both asexual and sexual 
reproduction that occurs in a single host (Fig 1.1). The life cycle begins upon ingestion of the 
infectious environmental stage (sporulated oocyst), by a host (Tandel et al., 2019; Gunasekera 
et al., 2020). These oocysts are extremely resilient due to their thick trilaminar walls and can 
survive for more than a week in chlorinated recreational water concentrations (>1 ppm) 
recommended by the Centers for Disease Control and Prevention for maintenance of 
recreational swimming pools (Gharpure et al., 2019). 
Once the oocysts are ingested, excystation triggered by temperature and pH conditions in 
the host’s gastrointestinal tract, occurs in the intestine, releasing four motile sporozoites 
(Widmer et al., 2007). These invade the intestinal epithelial cells on the luminal surface, where 
they undergo rounds of asexual reproduction to form trophozoites, meronts, and merozoites. 
Meronts develop four or eight nuclei, each incorporated into a merozoite, and once mature 
invade the surrounding host epithelial cells. These merozoites will either recycle as meronts 
and merozoites or develop into the sexual stages, the uni-nucleate macrogamont and the multi-
nucleated microgamont containing up to 16 non-flagellated microgametes. Rupturing of the 
microgamonts releases the microgametes, which fuse with the macrogamont forming a zygote.  
Within the host, the zygote undergoes meiosis, during which both thin-walled and thick-
walled oocysts are formed, each containing four potentially infective sporozoites. Thin-walled 
oocysts remain within the host leading to autoinfection and persistent infections, while thick-
walled oocysts are shed in the faeces into the environment, for ingestion by a new host (Nichols 
et al., 2008; Tandel et al., 2019; Gunasekera et al., 2020). The primary site of infection with C. 
hominis and C. parvum is the small intestine; however several gastric species including C. 
muris infect the stomach and numerous studies have reported Cryptosporidium to cause 
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Figure 1.1. Diagrammatic representation of the Cryptosporidium life cycle in the 
intestine (Gunasekera et al., 2020) 
 
 Clinical symptoms and treatment 
Clinical manifestations of Cryptosporidium infections vary from asymptomatic shedding 
of oocysts to acute diarrhoea and chronic disease (Reh et al., 2019). The general symptoms 
associated with cryptosporidiosis include diarrhoea, abdominal pain/cramps, vomiting and 
weight loss, and non-specific symptoms such as fatigue, low-grade fever, nausea and muscle 
weakness (Ehsan et al., 2016). In immunocompetent individuals, the symptoms are usually 
self-limiting, and individuals typically experience transient gastroenteritis lasting up to 2 weeks 
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and recover without treatment. Infections in immunocompromised individuals can be chronic 
and fatal (Wolska-Kusnierz et al., 2007), and in HIV patients, Cryptosporidium can be found 
in other organs including the pancreas, spleen, biliary tract and lungs (Sponseller et al., 2014). 
The GEMS and other studies to identify the aetiology and population-based burden of 
paediatric diarrhoeal disease revealed that Cryptosporidium is the second most important 
causative agent (after rotavirus) of moderate-to-severe diarrhoea and increased risk of death in 
children under five years in developing countries (Kotloff et al., 2013; Levine et al., 2020). 
Malnutrition, which impairs cellular immunity, is a significant risk factor for cryptosporidiosis 
(Gendrel et al., 2003). Cryptosporidium infections in children living in low-resource settings 
are also associated with growth retardation, impaired immune response and cognitive deficits 
(Mondal et al., 2009; Moore et al., 2010). 
Despite the clinical burden caused by Cryptosporidium infection, effective vaccines and 
treatments are still not available (Striepen, 2013; Sponseller et al., 2014). The only FDA 
approved drug, nitazoxanide, has had treatment failures in some immunocompetent individuals 
and is ineffective for immunocompromised individuals such as HIV-positive children (Amadi 
et al., 2002; Amadi et al., 2009; Sparks et al., 2015). 
 Detection and genetic characterisation of Cryptosporidium 
1.5.1 Microscopy  
Previously, microscopy coupled with various staining techniques was the principal 
technique for identification of Cryptosporidium oocysts (Garcia et al., 1983) and has been used 
extensively as an initial screening method for the detection of Cryptosporidium species in 
environmental, faecal and/or tissue samples (Quintero-Betancourt et al., 2003; Ng et al., 2012). 
However, this technique lacks sensitivity, is labour intensive, requires skilled personnel and is 
prone to human error (McHardy et al., 2014; Van den Bossche et al., 2015). Microscopy is also 
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unable to identify Cryptosporidium to the species level (Fall et al., 2003). Therefore, molecular 
characterisation is required (section 1.5.3) to identify species and track transmission (Fayer and 
Xiao, 2007). 
1.5.2 Immunological methods 
Immunological-based methods including immunofluorescence (IF) with monoclonal 
antibodies (mAbs), enzyme-linked immunosorbent assays (ELISA), reverse passive 
haemagglutination (RPH) and immunochromatographic assays have been developed. 
However, cross-reactivity with other microorganisms can occur due to the non-specific nature 
of antibody-based methods, limiting the use of these immunological methods (Fayer et al., 
2000; Chalmers and Katzer, 2013; Checkley et al., 2015). Indeed, some 
immunochromatographic assays have such low sensitivity and specificity that positives can 
only be considered “probable rather than confirmed” (Roellig et al., 2017; Lichtmannsperger 
et al., 2019). 
1.5.3 Molecular detection and characterisation of Cryptosporidium 
The use of molecular techniques including nested PCR and Sanger sequencing for 
identification of Cryptosporidium species and genotypes offers advantages over microscopy 
and immunological techniques in terms of sensitivity and specificity (Jex et al., 2008b; Elsafi 
et al., 2013; Adeyemo et al., 2018). Quantitative PCR (qPCR) assays have been developed for 
enumeration and detection of Cryptosporidium in faeces and water and have greater specificity, 
sensitivity and reproducibility than microscopy and immunological methods (Yang et al., 2013; 
Le Govic et al., 2016; Ahmed and Karanis, 2018). The 18S ribosomal RNA (rRNA) (Morgan 
et al., 1999; Xiao et al., 1999) and actin loci (Sulaiman et al., 2002) are most widely used for 
Cryptosporidium species identification, while the hypervariable 60-kDa glycoprotein (gp60) 
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gene (Strong et al., 2000; Peng et al., 2001) is used for transmission studies (Ng et al., 2010a; 
2010b). 
 The 18S rRNA locus  
The 18S rRNA is a multi-copy gene that is commonly used in the differentiation of 
Cryptosporidium species in humans, animals, and water samples. It is one of the most studied 
nuclear genes for phylogenetic analysis, mainly due to its slow rate of evolution that preserves 
ancient evolutionary events (Hillis and Dixon, 1991). The 18S gene has a semi-conserved and 
hypervariable region that is ideal for specific and sensitive detection and identification of 
Cryptosporidium spp. (Xiao, 2010; Ryan et al., 2014). 
 The actin locus 
The actin gene is a widely distributed and highly conserved single-copy microfilament 
protein that is thought to play a role in sporozoite gliding motility and penetration into host 
cells (Kim et al., 1992; Sulaiman et al., 2002). Sequence polymorphisms occur along the entire 
gene (Xiao et al., 2004), hence, sequencing the actin gene is a commonly employed 
characterisation technique that is primarily used as an additional phylogenetic marker to 
validate the multispecies nature of Cryptosporidium species after subsequent analysis of the 
18S rDNA (Wait et al., 2017). 
 The gp60 locus and other subtyping tools 
The 60-kDa glycoprotein (gp60) is the most polymorphic marker in the Cryptosporidium 
genome and as a result, is one of the most extensively used markers to subtype 
Cryptosporidium species, particularly C. hominis and C. parvum in humans, animals and 
wildlife (Xiao and Feng, 2017). This gene encodes a precursor protein that is cleaved to 
produce mature cell surface glycoproteins (gp45/gp40 and gp15) that are implicated in zoite 
attachment and invasion of enterocytes (Xiao, 2010; Ryan et al., 2014). DNA sequence analysis 
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of the 60 kDa glycoprotein (gp60) gene is one of the most common subtyping tools to 
characterise cryptosporidiosis infections and to link cases in outbreaks (Xiao, 2010). 
Most of the genetic heterogeneity in the gp60 gene is the variation in the number of serine-
coding tri-nucleotide repeats (TCA, TCG or TCT) in the 5’ end (gp40) of the coding region, in 
addition to extensive sequence divergence in non-repeat regions (Chalmers et al., 2019). Using 
this approach, an established subtype nomenclature has been developed to identify gp60 
subtype families (Sulaiman et al., 2005; Cama et al., 2007; Xiao, 2010; Chalmers et al., 2019). 
A subtype name starts with the species and subtype family designation that is identified from 
the sequence of a conserved region (e.g., Ia, Ib, Id, Ie, If, etc. for C. hominis; IIa, IIb, IIc, IId, 
etc. for C. parvum; IIIa, IIIb, IIIc, IIId, etc. for C. meleagridis). Variation in the number of 
TCA (represented by the letter A), TCG (represented by the letter G) or TCT (represented by 
the letter T) repeats within the trinucleotide repeat region identifies the subtypes within each 
family (Sulaiman et al., 2005; Xiao, 2010; Feng et al., 2011b; Chalmers et al., 2019). 
In some gp60 families, the presence of a single or contiguous copy of a repetitive sequence, 
Rn, or variations often exist (designed as R at the end of the subtype name). For instance, in C. 
hominis Ia, the repetitive sequence is AA(A/G)ACGGTGGTAAGG ending with the last 
AAAACGGTGAAGG repeat, while in C. parvum IIa, the repetitive sequence is ACATCA 
(Xiao, 2010; Chalmers et al., 2019). Thus, the name IeA11G3T3 indicates that the parasite 
belongs to C. hominis subtype family Ie and has 11 copies of the TCA repeat, 3 copies of the 
TCG repeat, and 3 copies of the TCT repeat in the trinucleotide repeat region of the gene. On 
the other hand, the subtype name IIaA15G2R1 indicates that the subtype belongs to C. parvum 
IIa subtype family, A15 indicates that the subtype has 15 copies of the TCA repeat, G2 
indicates that the subtype has two copies of the TCG repeat and one copy of the ACATCA 
repeat. 
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Subtyping gp60 genotypes has been an important addition to epidemiological and 
environmental investigations, particularly in determining the spread of outbreaks and linking 
cases to travel and suspected contamination sources (Chalmers et al., 2008; Xiao and Feng, 
2017; Chalmers et al., 2019). For instance, using this approach, C. hominis subtype IbA10G2 
has been found to be predominantly responsible for the majority of clinical cryptosporidiosis 
cases and C. hominis-associated outbreaks in developed countries including in Europe, 
Australia and the US (Waldron et al., 2011b; Widerström et al., 2014; Segura et al., 2015; 
Caccio and Chalmers, 2016; Efstratiou et al., 2017; Xiao and Feng, 2017). 
Until recently, PCR primers designed to target the gp60 gene of C. parvum and C. hominis 
could not efficiently amplify products from more divergent species and genotypes (Xiao and 
Feng, 2017). However, the use of whole-genome sequencing (WGS) has recently facilitated 
the development of subtyping tools targeting the gp60 gene of genetically divergent species 
such as C. ubiquitum, C. viatorum, Cryptosporidium skunk genotype, Cryptosporidium 
chipmunk genotype I, C. felis and C. canis (Fayer et al., 2001; Li et al., 2014; Guo et al., 2015; 
Stensvold et al., 2015; Yan et al., 2017; Rojas-Lopez et al., 2020; Jiang et al., 2021).  
Multi locus sequence typing (MLST) is increasingly being used to investigate 
Cryptosporidium at the intra species level (Chalmers et al., 2018). Multi locus sequence typing 
involves characterising numerous loci and provides a higher resolution and population genetic 
structure between species of Cryptosporidium as opposed to the single locus gp60 analysis 
(Tang et al., 2016; Yang et al., 2018). Despite funding being a major barrier, the introduction 
of a validated multilocus genotyping scheme to investigate Cryptosporidium cases and 
outbreaks is currently underway for many countries in Europe (Chalmers et al., 2018). 
MLST tools have been effectively used to track outbreaks and identify genetic 
recombination. For example, in a study by Feng et al. (2014), MLST analyses at eight loci was 
used to characterise the emergence of C. hominis IaA28R4 as a cause of sporadic and outbreak-
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related cases in the United States (US), and at least two origins of IaA28R4 were identified. In 
that study, linkage disequilibrium led to speculation that genetic recombination was the main 
driver in the emergence of the virulent IaA28R4 subtype in the US (Feng et al., 2014). In 
another study involving a more extensive analysis of 32 MLST markers, a largely clonal 
population structure for C. hominis IbA10G2 human samples from Peru was identified, which 
is consistent with most previous population studies on C. hominis (Kváč et al., 2013).  
 Applications of amplicon next-generation sequencing (NGS) in Cryptosporidium 
epidemiology 
Amplicon NGS analysis of Cryptosporidium, although in its infancy, is starting to be used 
in public health and monitoring investigations to identify the full range of species diversity and 
the extent of mixed Cryptosporidium infections. The key advantage of NGS amplicon analysis 
at the gp60 and other loci is the ability to detect multiple populations of Cryptosporidium 
species and low-abundance genotypes in mixed infections (Grinberg et al., 2013). Although 
currently more expensive than Sanger sequencing, the costs of NGS are reduced when samples 
are processed in batches, which makes NGS likely to be used in routine Cryptosporidium 
genotyping in the future (Ryan et al., 2017b). For example, recently based on WGS data, an 
amplicon-based typing method was developed on a panel of nine loci with 10 single nucleotide 
variants (SNV) that can be sequenced using a NGS platform (Beser et al., 2017). This was then  
used to identify ten sequence types among clinical C. hominis IbA10G2 isolates and 
determined that two large waterborne outbreaks in Östersund and Skellefteå in 2010 and 2011 
in Sweden were linked (Beser et al., 2017). An understanding of the role of Cryptosporidium 
co-infections is important to track Cryptosporidium transmission and has implications in 
designing vaccine and drug studies (Zahedi et al., 2017b). 
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Amplicon 18S NGS has also been recently investigated as a monitoring tool for 
simultaneous detection of Cryptosporidium parvum, Giardia duodenalis and Toxoplasma 
gondii in shellfish (DeMone et al., 2020). However, due to the conserved nature of the 18S 
locus, background amplification of oyster and other eukaryotic DNA is a major issue that needs 
to be overcome (DeMone et al., 2020). Similarly, generic eukaryotic 18S amplicon NGS failed 
to detect Cryptosporidium in wastewater in Australia and required Cryptosporidium-specific 
18S NGS to detect the parasite  (Zahedi et al., 2019). The application of 18S and gp60 amplicon 
NGS was recently conducted to investigate the Cryptosporidium species and subtypes from 
river water and riverbed sediments in South Africa (Mphephu et al., 2021). In that study, five 
Cryptosporidium species and a large diversity of Cryptosporidium subtypes (n = 92) 
corresponding to 22 subtype families were detected (Mphephu et al., 2021). When used in 
combination, Sanger sequencing, MLST and NGS are powerful tools that can be used to 
increase our knowledge of Cryptosporidium spp., taxonomy and outbreak investigations 
including swimming pool point-source outbreaks. 
 Transmission 
Cryptosporidium transmission occurs through faecal oral routes including direct contact 
with infected persons (person-to-person transmission) or animals (zoonotic transmission), 
ingestion of contaminated food (foodborne transmission) and water (waterborne transmission) 
(Xiao, 2010; Tandel et al., 2019). Several studies suggest that Cryptosporidium may also be 
transmitted via inhalation of aerosolised droplets or by contact with fomites contaminated by 
coughing (Sponseller et al., 2014). It has also been demonstrated that flies may play a role in 
the mechanical transmission of Cryptosporidium species that infect humans (Fetene and 
Worku, 2009; Zhao et al., 2014). Nonetheless, waterborne transmission accounts for the 
majority of reported Cryptosporidium outbreaks, particularly those associated with municipal 
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and recreational water contamination (Yoder and Beach, 2010; Chalmers et al., 2011a; Painter 
et al., 2015; Ryan et al., 2017a).  
1.6.1 Cryptosporidium in swimming pools and splash parks in Australia 
Cryptosporidium is the leading cause of recreational water associated gastroenteritis 
outbreaks worldwide including Australia (Efstratiou et al., 2017; Hlavsa et al., 2017; Ryan et 
al., 2017a). A major mode of Cryptosporidium transmission is via contamination of swimming 
pools (Ryan et al., 2017a) and it may be introduced into swimming pools by both symptomatic 
and asymptomatic bathers, mainly via poor swimmer hygiene (Castor and Beach, 2004; Yoder 
et al., 2010; Suppes et al., 2016).  
Several factors favour the spread of Cryptosporidium in swimming pools including (1) the 
high prevalence of accidental faecal releases (AFR), which can contain large numbers of 
infectious oocysts (Ryan et al., 2017a); (2) the ability of the thick-walled oocysts to withstand 
the normal chemical disinfectant levels such as chlorine and bromine used in swimming pool 
water (Korich et al., 1990; Painter et al., 2015); (3) the parasite’s very low infectious dose (1–
125 oocysts) (Murphy et al., 2015; Ryan et al., 2017a); and (4) prolonged host shedding since 
hosts can shed oocysts in faeces for an average of 7 days and up to 2 months after cessation of 
symptoms (Jokipii and Jokipii, 1986; Stehr-Green et al., 1987). 
Accidental Faecal Release (AFR) by swimmers are common events and have been 
reported to occur at least once a week (Castor and Beach, 2004; McManus et al., 2009). In 
Australia, swimming pool contamination by infected swimmers was the main reason 
implicated in almost all outbreaks analysed and swimming pools are the main risk factor 
associated with sporadic cryptosporidiosis in Australia (Table 1.2) (Robertson et al., 2002; 
Dale et al., 2010; Mayne et al., 2011; Waldron et al., 2011b; Ng-Hublin et al., 2015; Ng-Hublin 
et al., 2018) and in many parts of the world (Chalmers, 2012; Painter et al., 2015; Hlavsa et al., 
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2017; Polubotho et al., 2021). Although ozone and ultraviolet (UV) radiation are secondary 
treatments that can inactivate Cryptosporidium oocysts, in most cases, cryptosporidiosis 
outbreaks are still reported in association with ozone and UV treated pools worldwide 
(Boehmer et al., 2009; Ng-Hublin et al., 2015). Swimming while still shedding oocysts is 
another major contributing factor to outbreaks. One study in the US identified that 32% of 
patrons continued to swim despite being ill or within two weeks of having cryptosporidiosis 
symptoms (CDC, 2001). 
The first cryptosporidiosis outbreak associated with an indoor swimming pool in Sydney, 
was reported in 1995 with 70 cases between September 1994 and January 1995 (Lemmon et 
al., 1996). Cryptosporidium continues to be the major source of cryptosporidiosis outbreaks in 
disinfected recreational water venues, particularly in urban areas where it mostly infects 
children below the age of 5 and adult females (Lal et al., 2015). In Victoria alone, 70 outbreaks 
with 421 confirmed cases that were associated with aquatic facilities have been reported 
between 2013 and 2017 (Cullinan et al., 2020). 
Across Australia, there have been >129 reported cryptosporidiosis outbreaks linked to 
swimming pools between 1990 to present (Table 1.2). Molecular typing has only been 
conducted on 6.2% (n = 8) of outbreaks across Western Australia (WA), South Australia (SA) 
and New South Wales (NSW) (Ng et al., 2010a; Mayne et al., 2011; Waldron et al., 2011b; 
Ng-Hublin et al., 2015; Ng-Hublin et al., 2018). Cryptosporidium hominis IbA10G2 was the 
most predominant subtype in seven of the eight outbreaks (87.5%) that were subtyped at the 
gp60 gene. 
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1.6.2 Knowledge, attitudes and practices (KAP) of staff and patrons that contribute to 
swimming pool outbreaks 
Understanding the level of knowledge, attitudes, and practices (KAP) amongst both 
swimming pool patrons and staff is key to limiting Cryptosporidium transmission in pools. For 
example, a recent study identified that only ~25% of parents were aware that their children 
should abstain from swimming for at least two weeks following cessation of diarrhoeal 
symptoms (Munoz et al., 2016). In studies among staff, lack of knowledge regarding 
Cryptosporidium and its transmission was identified as the source of cryptosporidiosis 
outbreaks (Sorvillo et al., 1992; Bell et al., 1993; Louie et al., 2004; Ng-Hublin et al., 2015). 
Despite the importance of understanding KAP levels in relation to limiting Cryptosporidium 
transmission in swimming pools, very little research has been done in this area. A search of 
PubMed using combinations of the search terms “Knowledge, attitudes and practices”, 
“Cryptosporidium”, “swimming pools”, “patron behaviour” “staff behaviour” and “outbreaks”  
identified only seven documents and the terms “Cryptosporidium”, “swimming pools”, “patron 
behaviour” “staff behaviour” and “outbreaks”  alone identified 16 documents. This is clearly a 
knowledge gap that needs further investigation. 
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Table 1.2. Public swimming pool-associated outbreaks caused by Cryptosporidium spp. 
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NA Heilard et al., 
2000 






NA Stafford et al., 
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NA Heilard et al., 
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NA Puech et al., 2001 





(faeces) and pool 
water + Case-
control study 
NA Lemmon et al., 
1996 







NA Menzies, 2002 
NA – Not available 
WA = Western Australia, NSW = New South Wales, VIC= Victoria, QLD= Queensland,  
NT = Northern Territory, SA = South Australia 
a 2013-2017; 70 outbreaks, Cullinan et al. (2020) 
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b 2011; 2 outbreaks, Ng-Hublin et al. (2018) 
c 2006; 27 outbreaks, Dale et al. (2010) 
d 2005; 3 outbreaks, Dale et al. (2010) 
e 1990 – 2000 - 3 outbreaks, Menzies (2002) 
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1.6.3 Current knowledge gaps 
Significant knowledge gaps exist in our understanding of the transmission dynamics of 
cryptosporidiosis in swimming pools, particularly (1) lack of molecular typing and (2) lack of 
information on KAP levels. Currently Cryptosporidium species and subtype data are not 
included in the National Notifiable Diseases Surveillance System (NNDSS) or the Western 
Australian Infectious Disease Database (WANIDD). Similarly, very little is known globally 
about screening filter backwash and KAP levels in relation to Cryptosporidium in swimming 
pools and the behaviours and attitudes of swimming pool patrons and staff in WA have 
previously not been surveyed in detail. This is essential information to design effective 
educational programs for patrons and staff. 
 Thesis aims and objectives 
This literature review highlighted that knowledge gaps exist in relation to the contribution 
of Cryptosporidium to outbreaks of gastroenteritis associated with public swimming pools in 
Australia. A combination of molecular tools, contact tracing and questionnaire data may offer 
some advantages in determining the transmission dynamics and KAP levels of swimming pool 
patrons and staff to reduce the transmission of this important parasite in aquatic facilities. 
Specifically, the present research aimed to: 
1. Determine the species and genotypes of Cryptosporidium in clinical human 
faecal samples, particularly those related to public swimming pool outbreaks in 
Western Australia. 
2. Determine the knowledge, attitudes and practices of swimming pool patrons and 
staff in aquatic venues in Western Australia. 
3. Screen swimming pool filter backwash samples for Cryptosporidium.  
 28 
4. Develop recommendations for improved management and control of 
cryptosporidiosis in swimming pools. 
The central hypothesis of this thesis is that unhealthy swimming behaviours in public 
swimming pools in WA contribute to human cryptosporidiosis cases and that molecular typing 
is useful in cryptosporidiosis outbreaks of swimming pool origin. This research will provide 
information on the Cryptosporidium subtypes circulating in the general population, and 
through contact tracing, identify those associated with swimming pool outbreaks. It will also 
provide evidence on KAP levels among swimming pool patrons and staff in WA, which is 
essential information for formulating appropriate recommendations for the management of 
public swimming pools.    
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Chapter 2 
2 Retrospective analysis of Cryptosporidium species 
in Western Australian human populations (2015-
2018), and emergence of the C. hominis 
IfA12G1R5 subtype 
 Preface 
This chapter is a modified version of a published manuscript (Appendix A). 
Braima, K., Zahedi, A., Oskam, C., Reid, S., Pingault, N., Xiao, L., and Ryan, U, 2019. 
Retrospective analysis of Cryptosporidium species in Western Australian human populations 
(2015–2018), and emergence of the C. hominis IfA12G1R5 subtype. Infection, Genetics and 
Evolution, 73, 306-313. 
This chapter is a longitudinal analysis of Cryptosporidium cases in Western Australia between 
2015-2018. 
Highlights: 
• Sanger sequencing of Cryptosporidium species faecal samples from notified cases of 
cryptosporidiosis (n = 109) 
• Detection of 11 Cryptosporidium subtypes within human populations in Western 
Australia 
• Emergence of a previously rare C. hominis subtype IfA12G1R5 as main subtype in 
Western Australia in 2017 
• First report of C. viatorum from a human patient in Western Australia  
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 Introduction 
Cryptosporidium species are enteric protozoa that are a major cause of moderate-to-
severe diarrhoea in children younger than two years of age in South Asia and sub-Saharan 
Africa, and are a major risk factor for stunting and poor growth (Kotloff et al., 2013; Sow et 
al., 2016). Currently 38 Cryptosporidium species (now 46, refer Table 1.1) are recognised with 
C. parvum and C. hominis accounting for most infections in humans (Feng et al., 2018). 
Oocysts of most Cryptosporidium spp. are morphologically similar and therefore 
genotyping and subtyping tools are essential to characterise Cryptosporidium epidemiology 
and transmission dynamics. Studies worldwide have shown that C. hominis is the most 
dominant Cryptosporidium species infecting humans in most countries(Xiao, 2010). Although 
C. hominis is largely human specific, it has also been identified in domestic animals and 
wildlife hosts including sheep, goats, cattle, a dugong, non-human primates and kangaroos 
(Xiao, 2010; Zahedi et al., 2016; 2018). 
Several Cryptosporidium species have been reported in Australians including C. hominis, 
C. parvum, C. meleagridis, C. fayeri, C. andersoni, C. bovis, C. cuniculus, C. felis, a novel 
Cryptosporidium species most closely related to C. wrairi and the Cryptosporidium mink 
genotype (Koehler et al., 2014b; Ebner et al., 2015; Ng-Hublin et al., 2017; Ng-Hublin et al., 
2018). Sequence analysis of the 60-kDa glycoprotein (gp60) gene is one of the most commonly 
used subtyping tools for studying the transmission dynamics of Cryptosporidium. Over 10 
subtype families (Ia, Ib, Id, Ie, If, Ig, Ih, Ii, Ij and Ik) have been identified in C. hominis with 
subtype IbA10G2 responsible for the majority of C. hominis-associated outbreaks of 
cryptosporidiosis worldwide (Chalmers et al., 2010; Xiao, 2010; Widerström et al., 2014; 
Roelfsema et al., 2016; Feng et al., 2018). 
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Previous studies of cryptosporidiosis among human populations in Western Australia 
(WA) (2010a; Ng et al., 2010b; Ng-Hublin et al., 2015; 2017) and other areas of Australia (Jex 
et al., 2007; 2008a; Mayne et al., 2011; 2011b; Waldron et al., 2011a; Koehler et al., 2014b), 
have shown that subtype IbA10G2 is the most dominant subtype responsible for both C. 
hominis-associated outbreaks and sporadic cases of cryptosporidiosis in Australia, while C. 
hominis subtype IdA15G1 is the dominant subtype infecting Aboriginal populations in Western 
Australia (Ng-Hublin et al., 2017). In addition to C. hominis subtypes, a range of C. parvum 
(IIaA15G2R1, IIaA17G2R1, IIaA18G3R1, IIaA19G3R1, IIaA19G4R1, IIaA20G3R1, 
IIaA21G3R1, IIaA22G3R1, IIaA23G3R1, IIcA5G3a,  IIcA5G3R2,  IIdA15G1, IIdA18G2, 
IIdA19G2, IIdA22G2R1, IIdA23G1, IIdA24G1 and IIeA17G1), C. meleagridis 
(IIIeA18G2R2), C. fayeri (IVaA9G4T1R1, IVaA10G3T1R1) and C. cuniculus (similar to 
VbA25) subtypes have also been reported in Australians (Jex et al., 2007; O’Brien et al., 2008; 
Ng et al., 2010a; 2010b; Pangasa et al., 2010; Waldron et al., 2010; 2011b; 2011a; Ng et al., 
2012; Ng-Hublin et al., 2013a; Koehler et al., 2014b; Ng-Hublin et al., 2017; 2018). 
In the present study, we conducted a retrospective analysis of sporadic cryptosporidiosis 
cases reported in WA between 2015 and 2018 and examined the Cryptosporidium species and 
subtypes in Western Australian humans from a pathology laboratory. The study revealed 
extensive genetic diversity (11 Cryptosporidium subtypes belonging to four species in 109 
human faecal samples), and report the emergence of a previously rare C. hominis subtype, 
IfA12G1R5, as the dominant subtype in 2017. C. viatorum was also reported for the first time 
in Australia and was identified as a novel C. viatorum subtype. 
 32 
 Materials and Methods 
2.3.1 Stool collection and processing 
A total of 109 sporadic Cryptosporidium-positive human faecal samples were collected 
from a pathology centre in WA from 2015 to 2018 (Table 2.1), of which the presence of 
Cryptosporidium oocysts in each faecal sample was initially confirmed by microscopy. Briefly, 
fixed faecal smears were stained with heated Safranin (1% aqueous stain) and counterstained 
with Methylene-blue (1% aqueous stain) as previously described (Baxby et al., 1984). 
Cryptosporidium oocysts were then examined under oil immersion at x100 objective and were 
identified as bright orange-red, usually with a clear halo and ~5 µm in size. Positive samples 
were transported to Murdoch University in 75 ml faecal collection containers on ice and stored 
at 4ºC prior to DNA extraction and molecular analysis. 
2.3.2 DNA isolation 
Whole genomic DNA was extracted from each Cryptosporidium-positive faecal 
specimens using a MOBIO Power Soil DNA Isolation Kit (MOBIO, Carlsbad, California) 
following the manufacturer’s instructions with modifications as described by (Ng-Hublin et 
al., 2013b). Extraction reagent blanks (no faecal sample) were used in each extraction group. 
The purified DNA was stored at -20°C prior to PCR and subsequent molecular analyses. 
2.3.3 PCR amplification at 18S rRNA and gp60 gene 
Initial characterisation of Cryptosporidium species in faecal samples (n = 109) was 
carried out by nested PCR amplification and Sanger sequencing of an ~830 bp fragment of the 
Cryptosporidium 18S rRNA gene as described by Xiao et al. (2001). Samples that were 
characterised as C. hominis and C. parvum at the 18S locus, were then subtyped at gp60 locus 
using a nested PCR to amplify an ~830bp product as previously described (Strong et al., 2000; 
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Sulaiman et al., 2005). C. meleagridis and C. viatorum gp60 subtyping was also conducted as 
previously described (Stensvold et al., 2014; 2015). 
2.3.4 Sanger Sequencing and phylogenetic analysis 
Amplified DNA fragments were separated by agarose gel electrophoresis, purified for 
sequencing at both loci using an in-house filter tip method as previously described Yang et al. 
(2013), and sequenced in both directions using an ABI Prism™ Dye Terminator Cycle 
Sequencing kit (Applied Biosystems, Foster City, California) according to the manufacturer’s 
instructions, with annealing temperature of 57 oC for 18S rRNA as described by Zahedi et al. 
(2018); and 58 oC for both C. meleagridis (Stensvold et al., 2014) and C. viatorum (Stensvold 
et al., 2015). Sanger sequencing chromatogram files were imported into Geneious Pro 8.1.6 
(Kearse et al., 2012), and the nucleotide sequences were analysed and aligned with reference 
sequences from GenBank using Clustal W (http://www.clustalw.genome.jp). 
2.3.5 Demographic data and data analysis 
Laboratory identification numbers of the 109 faecal samples provided by the testing lab 
were cross-referenced with the Western Australian Notifiable Infectious Disease Database 
(WANIDD) to determine the age, gender, and public health unit (PHU) and were confirmed to 
be distinct (not replicates). Public Health Units (PHU) in Western Australia are divided into 3 
regions: Remote (Kimberly, Pilbara, Goldfields), Rural (Midwest, Wheatbelt, Southwest) and 
Metropolitan (North Metropolitan, South Metropolitan, East Metropolitan). A case that is not 
a resident of WA is denoted by NOWA. 
The population in the present study was then compared to the overall cryptosporidiosis 
notification data obtained from the Western Australian Notifiable Infectious Disease Database 
(WANIDD) from 2015–2018. Data analysis was conducted using Microsoft Excel® 2016 and 
GraphPad Prism® 5 software. 
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 Results 
2.4.1 Overall prevalence of Cryptosporidium species and subtypes detected in faecal 
samples 
All 109 microscopically Cryptosporidium positive samples from the pathology 
laboratory collected between 2015 and 2018, were successfully amplified and sequenced at 
both the 18S and gp60 loci and confirmed as Cryptosporidium-positive using molecular tools. 
Sequence typing at the 18S rRNA of the 109 cryptosporidiosis notifications identified four 
Cryptosporidium species; the majority of specimens identified were C. hominis (94/109), 
followed by C. parvum (12/109), C. meleagridis (2/109) and a single case of a novel C. 
viatorum variant (1/109) (Table 2.1, Figure 2.1). 
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Table 2.1. Distribution of Cryptosporidium species and gp60 subtypes identified in 
Western Australian humans from 2015 to 2018. 
Species Subtypes 
Year (No. positive) Subtype 
n (%) 2015 2016 2017 2018 
C. hominis IbA10G2 0 21 7 0 28 (25.7) 
IdA15G1 20 3 12 2 37 (33.9) 
IdA19 0 0 1 0 1 (0.9) 
IfA12G1R5 1 6 21 0 28 (25.7) 
       
C. parvum IIaA17G2R1 1 0 0 0 1 (0.9) 
IIaA18G3R1 0 2 1 2 5 (4.6) 
IIaA19G4R1 0 3 0 0 3 (2.8) 
IIcA5G3a 0 2 1 0 3 (2.8) 
       
C. meleagridis IIIbA23G1R1c 0 0 1 0 1 (0.9) 
IIIeA18G2R1 0 0 1 0 1 (0.9) 
       
C. viatorum XVaA3g 0 0 0 1 1 (0.9) 
       






Sequence analysis of the gp60 locus successfully identified 11 Cryptosporidium subtypes 
within the four Cryptosporidium species identified (Figure 2.1; Table 2.1). The most common 
subtype, C. hominis IdA15G1, was identified in 37/109 (33.9%) isolates. The next most 
abundant detected subtypes were C. hominis IbA10G2 and IfA12G1R5, which were identified 
in 28/109 (25.7%) isolates respectively (Table 2.1). The novel C. viatorum positive sample was 
subtyped as XVaA3g. Nucleotide sequences reported in the present study including the novel 
C. viatorum XVaA3g variant have been deposited in the GenBank database under the accession 










Figure 2.1. Cryptosporidium species and gp60 subtypes identified from reported cases of 
cryptosporidiosis (A). Overall Cryptosporidium species between (2015–2018), and (B). 
Percentage (%) of the three most commonly reported Cryptosporidium hominis subtypes 
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2.4.2 Demographic data 
Demographic data were obtained for all 109 individuals (Figure 2.1; Figure 2.2; Figure 
2.3). Males accounted for 41.3% (45/109) of the reported cases whereas 58.7% (64/109) were 
female Figure 2.2A). The highest number of cases occurred in the 0-4 years age group, 
comprised 45.0% (49/109) of reported cases, and of these, 23.9% (26/109) were male and 
21.1% (23/109) were female. A second peak was observed in the 20-24 to 35-39 age groups, 
which were predominantly female, i.e. 25.7% (28/109) (Figure 2.2A). Compared to the total 
Cryptosporidium notifications in WA, our study population did resemble closely the state-wide 
age-group trend (high notifications in the 0-4 age-group and the higher proportion of infected 
females between the 20-24 to 35-39 age groups) (Figure 2.2A; Figure 2.2B). Despite the similar 
trends in some of the age-groups however, it is not possible to infer that the samples genotyped 







Figure 2.2. Distribution of Cryptosporidium species in WA by age and gender between 
2015 and 2018. (A). Genotyped samples reported in this study (B). Total Cryptosporidium 
notifications in Western Australia (n = 1022). 
  












































Out of the present study population, the largest number of reports were obtained from 
the Kimberley 25.7% (28/109) and Pilbara 23.9% (26/109) regions, followed by the Southwest 
10.1% (11/109), East Metropolitan 9.2% (10/109), Midwest 8.3% (9/109), North Metropolitan 
7.3% (8/109), South Metropolitan 6.4% (7/109), Goldfields and Wheatbelt both at 3.7% 
(4/109) and non-WA residents with a total of 1.8% (2/109) cases (Table 2.2, Figure 2.3). C. 
hominis subtype IdA15G1 was identified predominantly in remote areas (31.2%, n = 34), with 
only 1.8% (n = 3) reported from rural and metropolitan areas combined (Table 2.2). C. hominis 
subtype IbA10G2 was identified in remote (11.9%, n = 13), rural (3.7%, n = 4), metropolitan 
(9.2%, n = 10) areas and a single non-WA resident was reported (0.9%, n = 1). Subtype 
IfA12G1R5 was identified across remote (6.4%, n = 7), rural (11.0%, n  = 12) and metropolitan 
areas (8.3%, n = 9) (Table 2.2). Due to the small number of cases from each Public Health 
Units (PHU), no statistically significant association could be made. The samples identified in 
the present study are not representative of the distribution of overall WA cases (Figure 2.3A; 
Figure 2.3B).
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Table 2.2. Distribution of Cryptosporidium species and gp60 subtypes reported from Western Australia health administrative regions and public health 
units (PHU) from 2015-2018.  
REGION PHU 









IbA10G2 IdA15G1 IdA19 IfA12G1R5 IIaA17G2R1 IIaA18G3R1 IIaA19G4R1 IIcA5G3a IIIbA23G1R1c IIIeA18G2R1 XVaA3g 
Remote KIM 5 19 - 3 - - 1 - - - - 28 (25.7) 
PILB 8 13 - 2 - 1 1 1 - - - 26 (23.9) 
GOLD - 2 - 2 - - - - - - - 4 (3.7) 
              
Rural MIDW 1 1 - 7 - - - - - - - 9 (8.3) 
CENT 1 - - 2 - - - - - 1 - 4 (3.7) 
STHW 2 - - 3 1 1 1 1 1 - 1 11 (10.1) 
              
Metropolitan NMET 6 - - 1 - - - 1 - - - 8 (7.3) 
SMET 1 1 - 4 - 1 - - - - - 7 (6.4) 
EMET 3 1 1 4 - 1 - - - - - 10 (9.2) 
              
NOWA NOWA 1 - - - - 1 - - - - - 2 (1.8) 








Figure 2.3. Distribution of Cryptosporidium notifications per Public Health Unit (PHU) 
in WA (A). Notifications from this study (B). Overall notifications reported in WA. (C). 
Map of Western Australia public health unit (PHU) classification of health 
administrative regions  












































































































The present retrospective study has identified that consistent with previous analysis (Ng 
et al., 2010b; Ng-Hublin et al., 2017; Ng-Hublin et al., 2018), C. hominis is the dominant 
Cryptosporidium species infecting humans in WA and was responsible for 86.2% of all 
infections. Cryptosporidium prevalence peaked in the 0–4 age group with a second spike in the 
21-30 and 31-40. A similar bimodal age pattern was seen in non-Aboriginal populations in a 
previous study in WA by Ng-Hublin et al. (2017), which was in contrast to a unimodal 
distribution of notifications for age groups in Aboriginal people, with 93.2% of cases reported 
in the 0–4 years age group Ng-Hublin et al. (2017). In the present study, the ethnicity of all 
individuals could not be determined and therefore comparisons between Aboriginal and non-
Aboriginal populations cannot be made. A bimodal age-related pattern of cryptosporidiosis is 
common in industrialised nations with the second peak attributed to transmission from infected 
children to predominantly female caregivers, through faecal-oral contamination during nappy 
changing for example (Robertson et al., 2002; Hunter et al., 2004; Yoder et al., 2012; Painter 
et al., 2015). 
The most prevalent C. hominis subtype in the present study (IdA15G1) was previously 
reported as the dominant subtype infecting Aboriginal people in WA (Ng-Hublin et al., 2017), 
whereas data from 2002-2017 has indicated that IbA10G2 mainly infected non-Aboriginal 
people from urban areas (Ng et al., 2010b; Ng-Hublin et al., 2017; Ng-Hublin et al., 2018). In 
the present study, IdA15G1 was also the dominant subtype in remote Public Health Units, 
which have a higher proportion of Aboriginal people compared to other PHUs.. Subtype 
IbA10G2 was dominant in both remote and metropolitan areas, whereas IfA12G1R5 was 
common across remote, rural and metropolitan areas. However, in the present study, as the 
Aboriginal status is unknown, correlations between the prevalence of subtype in Aboriginal 
versus non-Aboriginal populations cannot be made. 
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Sequence analysis of the gp60 locus successfully identified 11 Cryptosporidium 
subtypes, including the emergence of the IfA12G1R5 subtype in 2017 as the dominant subtype 
reported in WA, where it accounted for 46.7% of all typed cryptosporidiosis cases in that year. 
Until recently, IfA12G1R5 was a relatively rare subtype, that has previously only been 
identified in a few sporadic cryptosporidiosis cases in WA (Ng et al., 2010a) and the United 
Kingdom (Chalmers et al., 2008). In 2009, it was first reported in the United States in 
individuals with acquired immunodeficiency syndrome (AIDS) and was also responsible for 
an outbreak of cryptosporidiosis in Oregon, USA, associated with the care of an AIDS patient 
(Hlavsa et al., 2017). In 2013, it emerged as the dominant C. hominis subtype among sporadic 
and outbreak associated cases in the USA (for which Cryptosporidium subtyping data was 
available) (Hlavsa et al., 2017) and in 2016, was responsible for 36.6% (107/292) of sporadic 
cryptosporidiosis cases and was also associated with swimming pool cryptosporidiosis 
outbreaks in Alabama and Arizona (Hlavsa et al., 2017). The reason for the emergence of this 
subtype in 2017 in WA and in the USA is not well understood but may have come from 
recombination between related subtypes, as has been the case for the emergence of the hyper-
transmissible C. parvum IIaA15G2R1 subtype and C. hominis subtype IaA28R4 (Feng et al., 
2013; 2014; 2018). 
In the present study, C. hominis subtype IdA19 is only reported once, in 2017. This 
subtype was initially identified in a sporadic case in northern Ontario, Canada (Trotz-Williams 
et al., 2006), and is a rare C. hominis subtype infecting humans (Ong et al., 2008). It has been 
associated with a waterborne outbreak in North Battleford, Saskatchewan, Canada (Ong and 
Isaac-Renton, 2003; Ong et al., 2005), and recently has been reported worldwide in a number 
of countries including China (Feng et al., 2012; Wang et al., 2013a), Kenya (Mbae et al., 2015), 
Colombia (Sanchez et al., 2017), and as the predominant subtype in symptomatic patients in 
Lebanon (Osman et al., 2015). Despite being a relatively rare C. hominis subtype, IdA19 was 
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recently implicated in a massive waterpark-associated outbreak in Ohio, USA (Hlavsa et al., 
2017). 
Our results also showed that after C. hominis, C. parvum was the second most common 
species in sporadic cases. The C. parvum subtypes identified in the present study include three 
zoonotic IIa subtypes (IIaA17G2R1, IIaA18G3R1 and IIaA19G4R1) and the largely 
anthroponotically-transmitted IIc subtype family (IIcA5G3a). The IIa subtype family has been 
previously reported in numerous studies in developed countries (USA, Canada, Northern 
Ireland, Germany, Spain, The Netherlands, Italy and Australia) in both humans and animals, 
in particular calves (Xiao, 2010). An outbreak investigation by the Centers for Disease Control 
and Prevention (CDC) at a camp in North Carolina, USA, reported subtype IIaA17G2R1 in 
more than half of the outbreak infections, and the same subtype was identified in the animal 
faeces around the camp, further highlighting the zoonotic potential of this subtype (CDC, 
2011). 
C. parvum subtype IIaA18G3R1 is a common subtype in calves and humans in Ireland, 
Australia, and New Zealand (Thompson et al., 2007; Ng et al., 2008; Waldron et al., 2009; 
Zintl et al., 2009; Al Mawly et al., 2015). Similarly, subtype IIaA19G4R1 identified in the 
present study have previously been reported in Australia in both Aboriginal and non-Aboriginal 
Western Australians (Ng-Hublin et al., 2017). 
WANIDD confirmation of isolates identified the largely anthroponotically-transmitted 
C. parvum IIcA5G3a in three isolates and further analysis showed that all three patients had no 
history of international travel and were acquired locally. This finding may further support the 
anthroponotic transmission of this subtype in WA as the IIc subtype is considered 
predominantly anthroponotic in origin (Alves et al., 2003; Peng et al., 2003; Xiao et al., 2004; 
Xiao and Ryan, 2004). Subtype IIcA5G3j was however detected in hedgehogs (Erinaceus 
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europaeus) in Germany and the UK (Dyachenko et al., 2010; Sangster et al., 2016) and 
IIcA5G3q was identified in a goat in Ghana (Squire et al., 2017). 
Two C. meleagridis subtypes (IIIbA23G1R1c and IIIeA18G2R1) were identified, and 
although predominantly a bird parasite, C. meleagridis is commonly reported in humans and 
is the third most common Cryptosporidium species in humans in Australia (Ng-Hublin et al., 
2017). Studies on the anthroponotic versus zoonotic transmission of C. meleagridis are lacking 
but a study in Hubei Province, China, reported the same C. meleagridis subtype 
(IIIbA23G1R1c) in chickens and humans (Liao et al., 2018) and subtype IIIeA18G2R1 has 
been identified in animals inhabiting drinking water catchments in Australia (Zahedi et al., 
2018). 
This is the first report of C. viatorum from a human in WA and also the first report in 
Australia. A novel subtype, XVaA3g was identified which clustered within all other human C. 
viatorum sequences. C. viatorum was first described in 2012 from travellers returning to the 
United Kingdom from the Indian subcontinent (Elwin et al., 2012a) and has since been reported 
globally. It was initially thought to occur exclusively in humans, but subtype XVbA2G1 has 
recently been identified in the native Australian swamp rat (Rattus lutreolus), suggesting that 
rodents may be a reservoir host for this species (Koehler et al., 2018). 
 Conclusions 
Our study highlights the occurrence and emergence of Cryptosporidium subtypes that 
could potentially cause future disease outbreaks. Despite the dominance of the C. hominis 
IbA10G2 subtype in non-Aboriginal humans in WA from as early as 2002 until 2017, for the 
first time we report the emergence of the previously rare C. hominis subtype IfA12G1R5 as 
the dominant subtype in 2017. We also report for the first time, the identification of C. viatorum 
in Australia and the characterisation of a novel C. viatorum subtype. Knowledge of 
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mechanisms behind the emergence of virulent C. hominis subtypes such as the IfA12G1R5 and 
other successful subtypes infecting humans is critical to improved understanding of 
cryptosporidiosis epidemiology. Whole Genome Sequencing (WGS) of these novel emerging 
subtypes is essential to provide us with new tools in the characterisation of C. hominis subtypes 
for more in-depth analysis.  
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Chapter 3 
3 Zoonotic infection by Cryptosporidium fayeri 
IVgA10G1T1R1 in a Western Australian human 
 Preface 
This chapter is a modified version of a published manuscript (Appendix B). 
Braima, K., Zahedi, A., Oskam, C., Austen, J., Egan, S., Reid, S., Ryan, U, 2021. Zoonotic 
infection by C. fayeri IVgA10G1T1R1 in a Western Australian human. Zoonoses and Public 
Health, 68 (4), 358-360. 
This chapter describes the detection and characterisation of C. fayeri that caused diarrhoeal 
illness in a human in WA 
Highlights: 
• Zoonoses resulting from human encroachment into wildlife areas is a significant public 
health issue and we report the detection and characterisation of Cryptosporidium fayeri, 
a marsupial species of parasite that caused diarrhoeal illness in a human 
• This is only the second report of this species in humans and subtyping matched C. fayeri 
isolates from marsupials in the same locality 
• Next generation sequencing confirmed the absence of mixed infections with other 
Cryptosporidium species  
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 Introduction 
Continued human encroachment into wildlife-populated areas and the expansion of 
wildlife into urban areas increases the risk of spill over and spill back of zoonotic pathogens. 
Cryptosporidium is an important protozoan parasite that infects a wide range of hosts and is 
transmitted primarily by faecal-oral contamination. Cryptosporidial infections in humans and 
animals can range from asymptomatic to severe diarrhoea and can cause prolonged and 
sometimes fatal infections in immunocompromised humans (Gerace et al., 2019). 
The parasite is a major cause of diarrhoeal illness and mortality in young children (GBD, 
2017) and the only US Food and Drug Administration (FDA) approved drug, nitazoxanide, has 
poor efficacy in immunocompromised individuals (Amadi et al., 2009). Currently, 42 
Cryptosporidium species (now 46, refer Table 1.1) are recognised with C. hominis and C. 
parvum the main species infecting humans (Zahedi and Ryan, 2020).  
On 1 March 2020, a 37-year-old immunosuppressed female treated for acute myeloid 
leukaemia in Western Australia (WA) was admitted to hospital with a 3 day history of nausea, 
vomiting, abdominal pain and diarrhoea as well as a worsening maculopapular rash over her 
neck and torso. The patient was diagnosed with cryptosporidiosis when oocysts were detected 
in a faecal sample by microscopy. The patient had no known recent travel history or contact 
with ill acquaintances or wildlife. 
 Materials and Methods 
On 3 March 2020, routine stool microscopy at a local pathology laboratory was positive 
for Cryptosporidium species. On 15 March 2020, DNA was extracted from the sample using a 
Qiagen DNeasy tissue kit (Qiagen, Hilden, Germany) and Cryptosporidium was amplified and 
sequenced at the 18S rRNA (18S) locus (Xiao et al., 2001) resulting in the identification of C. 
fayeri. As a consequence, C. fayeri specific primers targeting the gp60 locus (Power et al., 
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2009) were then used to subtype the sample. Amplicon next generation sequencing (NGS) 
using gp60 primers was also conducted on the sample to determine the presence of mixed C. 
parvum, C. hominis and C. cuniculus infections as previously described (Zahedi et al., 2017b). 
This study has prior approval from the Murdoch University Human Research Ethics 
approval number: 2017/239, and WA Department of Health HREC number: 2018/23. 
 Results 
Subtyping at the gp60 locus identified C. fayeri subtype IVgA10G1T1R1, confirming 
the identification of C. fayeri at the 18S locus. The 18S and gp60 nucleotide sequences of the 
C. fayeri identified in the present study were deposited in GenBank under the accession 
numbers MT928783, and MT952954, respectively. Amplicon next generation sequencing 
failed to match 100% pairwise identity and query cover with reference sequences, indicating 
no mixed C. parvum, C. hominis and C. cuniculus infections within the C. fayeri isolate. 
Following the initial detection of Cryptosporidium oocysts in the patient stool sample 
on March 3rd, the patient was put on a 3 day course of nitazoxanide. On the 11th of March 2020, 
Cryptosporidium was not detected on limited microscopic examination, however a full parasite 
examination was not requested. In addition, diarrhoeal symptoms were still ongoing when the 
patient was discharged into palliative care. 
 Discussion 
The present study is only the second report of C. fayeri infection in a human host. In the 
previous study, a 29-year-old immunocompetent woman in New South Wales (NSW), 
Australia, sought care because of prolonged gastrointestinal illness (Waldron et al., 2010). In 
that study, the patient was diagnosed as positive for Cryptosporidium using an enzyme 
immunoassay (EIA) and C. fayeri subtype IVaA9G4T1R1 was identified upon molecular 
 51 
screening (Waldron et al., 2010). The same C. fayeri subtype had previously been identified 
from eastern grey kangaroos (Macropus giganteus) inhabiting the main drinking water 
catchment for Sydney (Power et al., 2009). The patient resided in a national forest in NSW and 
had frequent contact with marsupials, suggesting zoonotic transmission (Waldron et al., 2010). 
In the present study, the C. fayeri subtype IVgA10G1T1R1 identified in the 
immunosuppressed female patient, had previously been reported in western grey kangaroos 
(Macropus fuliginosus) and rabbits (Oryctolagus cuniculus) in drinking water catchments in 
WA and NSW, respectively (Zahedi et al., 2018). Marsupials are the dominant animals 
inhabiting drinking water catchments in Australia, with the majority infected with C. fayeri 
and /or C. macropodum (Nolan et al., 2013; Koehler et al., 2016; Zahedi et al., 2018). In 
addition to apparently host-specific genotypes such as brushtail possum genotype I (Hill et al., 
2008), kangaroo genotype I (Yang et al., 2011) and Tasmanian devil genotype I (Wait et al., 
2017), a range of additional species, many of which are zoonotic have been identified in 
marsupials including C. hominis, C. parvum, C. muris (Warren et al., 2003; Hill et al., 2008; 
Ng et al., 2011; Dowle et al., 2013), C. xiaoi (Yang et al., 2011), C. ubiquitum and C. 
meleagridis (Vermeulen et al., 2015), C. cuniculus (Koehler et al., 2014a), C. galli  (Wait et 
al., 2017) and C. erinacei (Zahedi et al., 2018). 
The absence of other Crypotsporidium species using NGS suggests infection by a single 
C. fayeri subtype. Identification of C. fayeri clinical infection in a human patient is a public 
health concern, as until recently this species was thought to be host-adapted, but has now been 
reported in two human patients, one of which was immuno-competent. The source of the C. 
fayeri infection in the immunosuppressed patient in the present study is unknown, but potential 
sources include contaminated water. Nitazoxanide has previously been reported to be 
ineffective in immunocompromised individuals (Amadi et al., 2009) and in the present study 
the clinical symptoms were not resolved in the patient. Clearly further studies are required to 
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determine the zoonotic potential and transmission dynamics of C. fayeri and of wildlife-
associated Cryptosporidium in general. 
 Conclusions 
In addition to the current use of microscopy, routine molecular typing in diagnostic 
laboratories to better understand the transmission dynamics of Cryptosporidium species in 
humans, needs to be conducted. This study reinforces the need to consider cryptosporidiosis as 
a cause of gastrointestinal disease in immunocompromised people. It also highlights the need 
for enhanced infection control measures for at least 14 days after symptoms cease to avoid 
secondary transmission. This is especially important given the patient continued to be 




4 Molecular analysis of cryptosporidiosis cases in 
Western Australia in 2019 and 2020 supports the 
occurrence of two swimming pool associated 
outbreaks and reveals the emergence of a rare C. 
hominis IbA12G3 subtype 
 Preface 
This chapter is a modified version of a published manuscript (Appendix C): 
Braima, K., Zahedi, A., Egan, S., Austen, J., Xiao, L., Feng, Y., Witham, B., Pingault, N., 
Perera, S., Oskam, C., Reid, S., Ryan, U, 2021. Molecular analysis of cryptosporidiosis cases 
in Western Australia in 2019 and 2020 supports the occurrence of two swimming pool 
associated outbreaks and reveals the emergence of a rare C. hominis IbA12G3 subtype. 
Infection, Genetics and Evolution, 92, 104859. 
This chapter describes the epidemiology of two cryptosporidiosis outbreaks related to public 
swimming pools in WA. 
Highlights: 
• Analysis of swimming pool-associated cryptosporidiosis outbreaks in Western 
Australia. 
• Next Generation, Sanger sequencing and multi locus typing of outbreak cases. 
• Two separate outbreaks linked to aquatic centres via typing and tracing. 
• Emergence of a relatively rare C. hominis subtype IbA12G3 in Australia.  
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 Introduction 
The Global Enteric Multicenter Study (GEMS), which was conducted in the first decade 
of the millennium, identified Cryptosporidium as a major cause of moderate to severe diarrhoea 
and increased risk of death in children under 5-year-olds in developing countries (Kotloff et 
al., 2013; Levine et al., 2020). The parasite is also the leading cause of recreational water 
associated gastroenteritis outbreaks worldwide (Efstratiou et al., 2017; Hlavsa et al., 2017; 
Ryan et al., 2017a). This is largely due to the resistance of the environmental stage of the 
parasite, the oocyst, to normal chlorine levels used for pool disinfection and its very low 
infectious dose (1–125 oocysts) (Murphy et al., 2015; Ryan et al., 2017a). Cryptosporidium 
may be introduced into swimming pools by both symptomatic or asymptomatic bathers, mainly 
via poor swimmer hygiene (Yoder et al., 2010). 
Among the 44 recognised Cryptosporidium species (now 46, refer Table 1.1), C. hominis 
and C. parvum are the main species infecting humans (Ježková et al., 2021b), but more than 
20 other Cryptosporidium species and genotypes have been identified in humans (Xiao and 
Feng, 2017). Subtyping of Cryptosporidium is most commonly conducted using sequence 
analysis of the hypervariable glycoprotein 60 (gp60) locus (Xiao and Feng, 2017), with the C. 
hominis IbA10G2 subtype, one of the most commonly reported subtypes in both sporadic cases 
and outbreaks worldwide (Chalmers et al., 2010; Ng et al., 2010b; Fournet et al., 2013). 
In Australia, cryptosporidiosis is a nationally notifiable disease. Between 2001 and 2007, 
contamination of swimming pools with Cryptosporidium spp. was linked with almost all 
(41/42) reported outbreaks of recreational water associated gastroenteritis (Dale et al., 2010). 
Between 2013 and 2017 in Victoria, Australia, 70 outbreaks of cryptosporidiosis were 
associated with aquatic facilities, with 421 confirmed cases (Cullinan et al., 2020). Relatively 
few molecular typing studies have been conducted on swimming pool associated outbreaks 
worldwide and very few in Australia but C. hominis IbA10G2 subtype has been linked to 
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cryptosporidiosis outbreaks in Western Australia (Ng-Hublin et al., 2015) and Sydney (Mayne 
et al., 2011; Waldron et al., 2011a). 
In the January to March period of 2019, 59 cases of cryptosporidiosis were reported to the 
Western Australian Notifiable Infectious Disease Database (WANIDD), while 400 cases were 
notified in the same period in 2020. A subset of these cases were investigated using both contact 
tracing and a combination of molecular tools including (1) Sanger sequencing of 18S ribosomal 
DNA and gp60 amplicons to identify species and subtype, (2) next generation sequencing 
(NGS) at the gp60 locus to identify mixed infections and (3) multi locus sequence typing 
(MLST) analysis to determine if any geographic substructure was present. 
 Materials and methods 
4.3.1 Sample collection, storage and initial contact tracing 
Faecal samples were collected as a subset of the total number of cases reported to 
WANIDD in WA in 2019 (n = 59) and 2020 (n = 400). Overall, 101 Cryptosporidium-positive 
human faecal samples submitted to three local clinical pathology laboratories between 
February and April 2019 (18 samples) and January and April 2020 (83 samples) in WA were 
analysed. The presence of Cryptosporidium in faecal samples was initially confirmed by 
microscopy using a modified Ziehl-Neelsen stain microscopy (n = 48) in one pathology 
laboratory and using the BD Max Enteric Parasite Real-time PCR panel Assay (n = 35) and 
Roche TIB Molbiol faecal multiplex PCR (n = 18) at the other two pathology centres. Upon 
collection, the samples were stored at 4ºC prior to DNA extraction and subsequent molecular 
analysis. 
All cases were cross-referenced with WANIDD to determine the age, gender and public 
health unit (PHU) and were confirmed to be distinct (not replicates). Public Health Units in 
WA are divided into Metropolitan (North Metropolitan, South Metropolitan, East 
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Metropolitan) and country public health regions (Kimberley, Pilbara, Goldfields, Midwest, 
Wheatbelt, Southwest, Great Southern). Thirty-six and 143 of the total cases reported in 
WANIDD in 2019 and 2020 respectively, were contacted by Local Governments 
Environmental Health Officers and/or a WA Department of Health epidemiologist by 
telephone after the initial cryptosporidiosis diagnosis to assist with investigations and 
determine the point source of the infections in 2019 and 2020 respectively. A Cryptosporidium 
case questionnaire was administered via the WA Department of Health staff. It is designed to 
gather exposure and other epidemiological information from when there are three or more cases 
in a postcode (with specimen dates within a two-week period). It comprises questions related 
to travel, contact, swimming and animal or other environmental exposures. 
4.3.2 DNA extraction and PCR amplification 
Total genomic DNA was extracted  from all faecal samples (~250 mg ) obtained in 2019 
(n = 18) and 2020 (n = 83) using a DNeasy PowerSoil Kit (QIAGEN, Germany) with 
modifications as previously described (Ng-Hublin et al., 2013b) and stored at -20ºC until 
analysis. The extracted DNA samples were initially characterised using a nested PCR targeting 
the 18S rRNA (18S) locus (Xiao et al., 2001). Samples that were identified as C. hominis or C. 
parvum at the 18S locus were subsequently subtyped using a nested PCR at the gp60 locus as 
previously described (Sulaiman et al., 2005). Cryptosporidium meleagridis (Stensvold et al., 
2014) and C. fayeri  (Power et al., 2009) were typed using separate gp60 specific subtyping 
primer pairs, respectively. 
4.3.3 Sanger sequence analysis 
Amplified DNA fragments of all 101 samples were separated by gel electrophoresis and 
purified using an in-house filter tip method as previously described  (Yang et al., 2013). The 
purified DNA isolates were sequenced in both directions using an ABI Prism™ Dye 
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Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, California) according to 
the manufacturer’s instructions. The 18S and gp60 nucleotide sequences identified in the 
present study were deposited in GenBank under the accession numbers (MT928776-
MT928784) and (MT952947-MT952955), respectively. 
4.3.4 Next generation amplicon sequencing (NGS) and bioinformatics analysis 
All 101 samples subtyped by Sanger sequencing were included in the NGS analysis. Next 
generation sequencing was conducted by amplifying a partial fragment of Cryptosporidium 
gp60 locus on a Illumina MiSeq platform as previously described (Zahedi et al., 2017b) and as 
per standard protocols for the MiSeq platform (Illumina Demonstrated Protocol: Metagenomic 
Sequencing Library Preparation). No-template PCR controls (NTC) and extraction reagent 
blanks were included in all reactions. Libraries were sequenced on an Illumina MiSeq™ using 
v3 chemistry (2 x 300 paired end). Bioinformatic analysis of amplicon sequences was 
performed as previously described (Zahedi et al., 2017b). 
4.3.5 Multi locus sequence typing (MLST) 
A subset (n = 38) of the two predominant C. hominis subtypes identified (IbA12G3 and 
IdA15G1) were selected for multi locus sequence typing (MLST) analysis at five polymorphic 
markers targeting genes encoding a 47 kDa protein (cp47), a hydroxyproline-rich glycoprotein 
(dz-hrgp), a serine repeat antigen (msc6-7), and a mucin-like protein gene (mucin1) (Gatei et 
al., 2006; Gatei et al., 2007). The subset of samples were randomly selected to represent all 
PHUs from which positives were identified; from the 2019 cases, a total of 14 IdA15G1 
subtype cases from the Kimberley (n = 8), Pilbara (n = 5), and Goldfields (n = 1) PHU’s were 
analysed, while 24 IbA12G3 representative samples from the 2020 outbreak from North 
Metropolitan (n = 5), South Metropolitan (n = 5), East Metropolitan (n = 5), Pilbara (n = 5), 
Midwest (n = 2), and the Wheatbelt (n = 2) PHU were analysed. PCR reactions were conducted 
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in 25µl volumes, using 1µl of extracted DNA in the primary PCR, and 1µl in the secondary 
PCR and conditions as previously described (Mallon et al., 2003; Tanriverdi et al., 2003; 
Tanriverdi et al., 2006). Amplicons were sequenced by Sanger sequencing in both directions 
as described above. The MLST loci were analysed, trimmed and concatenated using Geneious 
10.2.6 (Kearse et al., 2012), and aligned with reference sequences from GenBank using 
ClustalW (http://www.clustalw.genome.jp). 
 Results 
4.4.1 Epidemiology and links to aquatic centres 
Among the samples collected in 2019 (n = 18), most samples originated from the country 
PHUs, the Kimberley (n = 12), Pilbara (n = 2), Goldfields (n = 1) and Midwest (n = 1). Two 
cases were acquired overseas (Nepal and Indonesia) by residents living in the North and East 
Perth metropolitan PHUs (Table 4.1). Of the 18 cases from 2019, six were female and 12 were 
male and the cases ranged in age from less than 1 to 55 years of age (data not shown). In 2019, 
12 of the 18 typed cases resided in the same postcode, four were interviewed by Local 
Government Environmental Health Officers (EHOs) and reportedly swam at the same aquatic 
centre in the Kimberley region. All cases developed symptoms after swimming. Two siblings 
from the Pilbara were diagnosed, while one case each was reported from the Midwest and 
Goldfields PHUs (Table 4.1).
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Table 4.1. Cryptosporidium spp. and subtypes identified by Sanger sequencing and NGS in the 2019 and 2020 outbreaks per individual 
public health unit (PHU) in WA. 
   Public Health Unit (PHU)  
Year Species Subtype NMET SMET EMET KIMB PILB MIDW CENT GOLD OS Total 
2019 C. hominis IaA17R3 - - - - - - - - 1 1 (5.5%) 
  IbA10G2 - - - - - - - - 1 1 (5.5%) 
  IdA15G1 - - - +12 2 1 - 1 - 16 (89.0%) 
  *IdA14    *2 *2   *1   
  Total - - - 12 2 1 - 1 2 18 (100.0%) 
             
2020 C. hominis IbA12G3 #37 13 12 - 7 2 2 - - 73 (88.0%) 
 IbA9G3 - 2 - - - - - - - 2 (2.4%) 
 *IdA14 - - - - *3 - - - -  
 IdA15G1 - - - - 3 - - - - 3 (3.6%) 
 IeA12G3T3 1 - - - - - - - - 1 (1.2%) 
 C. parvum IIaA18G3R1 - - - - - - - - 1 1 (1.2%) 
  *IIaA16G3R1 *1          
 C. meleagridis IIIbA23G4R1 2 - - - - - - - - 2 (2.4%) 
 C. fayeri IVbA10G1T1R1 - - 1 - - - - - - 1 (1.2%) 
  Total 40 15 13 0 10 2 2 0 1 83 (100.0%) 
NMET (North Metropolitan), SMET (South Metropolitan), EMET (East Metropolitan), KIM (Kimberley), PILB (Pilbara), MIDW (Midwest), CENT 
(Wheatbelt), GOLD (Goldfields), OS (infection acquired overseas).* co-infections with IdA15G1 detected by NGS but not Sanger sequencing;+ cases were all 
from the same Postcode; #  five subtyped cases linked to three separate swimming pools outbreaks. 
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In 2020 nearly half of all samples came from reported cases within the North 
Metropolitan PHU (see Table 4.1 for details). One case was a German visitor. Of the 83 typed 
cases, 47 were female and 36 were male and the cases ranged in age from less than 1 to 73 
years of age (data not shown). Interviews of 143 notified cases from the first quarter of 2020 
by either Local Government EHOs or OzFoodNet staff identified nine point-source outbreaks 
at recreational aquatic centres. From 2020, among those 143 interviewed, only 16 had 
genotyping results; five of the cases subtyped were associated with three separate outbreaks, 
which were all in the North Metropolitan region (Table 4.1). 
4.4.2 Cryptosporidium species and subtypes identified by Sanger sequencing 
All the 101 faecal samples were successfully analysed by Sanger sequencing of the gp60 
locus. In 2019, three C. hominis subtypes were identified;  IdA15G1 – 89.0% (16/18), IaA17R3 
- 5.5% (1/18), and IbA10G2 - 5.5% (1/18). In 2020, a total of 83 samples representing four 
Cryptosporidium spp. and seven subtypes were identified: C. hominis IbA12G3 subtype - 
88.0% (73/83), IbA9G3 - 2.4% (2/83), IdA15G1 - 3.6% (3/83), IeA12G3T3 - 1.2% (1/83), C. 
parvum IIaA18G3R1 - 1.2% (1/83), C. fayeri IVbA10G1T1R1 - 1.2% (1/83), a C. meleagridis 
IIIgA23G4R1 subtype variant - 2.4% (2/83) (Table 4.1). Sequence alignment analysis with 
reference C. meleagridis sequences from GenBank revealed that the IIIgA23G4R1 subtype 
variant identified in the present study exhibited 99.3% similarity to C. meleagridis 
IIIgA25G3R1 subtype samples from two chickens from a market in Brazil (da Cunha et al., 
2018). 
4.4.3 Next generation sequencing (NGS) 
Amplicon NGS identified mixed Cryptosporidium infections in 5/16 C. hominis 
IdA15G1 subtypes from 2019 and in all three C. hominis IdA15G1 subtypes detected in 2020. 
In all eight cases, co-infections with C. hominis IdA14 subtype were identified. All mixed C. 
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hominis IdA14 cases were only reported from the Pilbara (2 cases each in 2019 and 2020), 
Goldfields (1 case) and the Kimberly (2 out of 12 C. hominis IdA15G1 cases) in 2019. The 
single sample positive for C. parvum IIaA18G3R1 subtype identified in 2020, had a co-
infection with C. parvum subtype IIaA16G3R1 (1.2%). Overall, in 2019, approximately 28% 
(5/18) of the samples typed had mixed infections, compared to ~5% (4/83) for 2020 (Table 
4.1). 
4.4.4 Multi locus sequencing 
Multi locus sequence typing was carried out on a subset (n = 38) of total samples;  all C. 
hominis IdA15G1 (n = 19) and a subset IbA12G3 (n = 19) from 2019 and 2020 at the cp47 
(387 bp), dz-hrgp (456 bp), gp60 (828 bp), msc6-7 (465 bp), and mucin1 (777 bp) genes to 
produce a 2,913 bp MLST fragment of concatenated sequences. One C. hominis IdA15G1 
sample from 2019 and 2 samples from 2020 had a 6 bp nucleotide (ATGATA) insertion at the 
cp47 gene. Representative sequences of cp47, dz-hrgp, msc6-7, gp60 and mucin1 loci obtained 
in the present study were deposited in GenBank under Accession numbers MW855868-
MW855877. 
 Discussion 
The present study combined conventional epidemiological tracing and molecular analyses 
to examine a subset of cases reported to the WANIDD in WA in 2019 and 2020. In the first 
quarter of 2019, 59 cases of cryptosporidiosis were reported in WA and of the ~30% (18/59) 
of cases that were genotyped, C. hominis IdA15G1 was identified in 16/18 WA acquired cases. 
The remaining two cryptosporidiosis infections acquired by WA residents whilst overseas in 
Indonesia and Nepal, were identified as C. hominis IbA10G2 and 1aA17R3, respectively. 
Subtype IaA17 is a rare subtype that has previously been reported in children in rural Ghana 
(Eibach et al., 2015). Subtype IdA14 is also rare and has been reported in a pediatric hospital 
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in China (Feng et al., 2012). Subtype IbA10G2 is one of the major subtypes reported in sporadic 
and outbreak cases worldwide including Australia (Ng et al., 2010b), but has not been reported 
in any subtyping in WA since 2018 (Braima et al., 2019). 
The C. hominis IdA15G1 subtype has previously been reported as the dominant subtype 
infecting Aboriginal people in WA (Ng-Hublin et al., 2018). Consistent with this, all the 
IdA15G1 subtype cases detected in 2019 were from country regions (n = 16), where Aboriginal 
people comprise 30 – 40% of the population, in comparison to just 1.5% of the metropolitan 
WA population (Ng-Hublin et al., 2017). Of the 18 typed samples from 2019, amplicon NGS 
identified mixed infections (with C. hominis 1dA14) in five of the IdA15G1 samples. The 
possibility of PCR polymerase slippage in the mixed infections cannot be completely ruled out. 
However strict laboratory and bioinformatic processes (Elbrecht et al., 2018) were 
implemented in the present study including; primer design (without degenerate bases), use of 
high fidelity Taq and removal of low abundant and chimeric sequences as outlined in Zahedi 
et al. (2017). There was also a lack of mixed IdA15G1 infections observed in the remaining C. 
hominis (83.3%) from the Kimberly. Therefore, it is most likely that C. hominis sequences 
identified in the present study represent true biological sequences. 
Multi locus sequence typing identified a 6 bp insertion in the microsatellite repeat region 
of the cp47 gene in one of the IdA15G1 subtype samples from 2019 but no other sequence 
variation was detected. Contact tracing identified two cases linked to the same swimming pool 
in the Kimberley. A previous study reported a cryptosporidiosis outbreak in the Kimberley 
region in 2012, with 18 notified cases of cryptosporidiosis linked to a swimming pool in 
Broome, WA (Ng-Hublin et al., 2015). In that study, C. hominis IbA10G2 subtype was detected 
in all eight human samples that were typed and in one water sample (Ng-Hublin et al., 2015) 
and the outbreak was linked to an individual returning from India with gastroenteritis who 
continued to swim at the pool against their doctor’s advice. 
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In the first quarter of 2020, 400 cryptosporidiosis cases were reported and of the ~21% 
(83/400) of cases that were typed, C. hominis IbA12G3 emerged as the predominant subtype, 
responsible for nearly 88.0% (73/83) of typed cases from that quarter. Until recently, C. 
hominis IbA12G3 was a rare subtype and was first reported in a single human case from the 
United Kingdom in 2010 (Pangasa et al., 2010) and then in sporadic cases in South Africa 
(Samra et al., 2016), Mexico (Urrea-Quezada et al., 2018), the United Kingdom (Chalmers et 
al., 2019), Spain (Millán et al., 2019) and most recently in four cases in Southern Ireland 
(O’Leary et al., 2020). Sequence comparisons of gp60 amplicons showed 100% sequence 
similarity between the IbA12G3 positives in the present study with the previously reported 
human cases. In one IbA12G3 subtype identified, the order of the trinucleotide repeats was 
different, but the number of TCA and TCG repeats was the same (i.e. they still added up to 12 
TCA and 3 TCG repeats) and this variant has been reported in non-human primates, Rhesus 
macaques (Macaca mulatta) in China (Karim et al., 2014). In 2017, IbA12G3 was linked with 
a swimming pool outbreak in the United Kingdom involving four confirmed cases (Chalmers 
et al., 2019). In the present study, five IbA12G3 subtype cases (2, 2 and one case) from the 
large community outbreak in 2020 were each linked to three separate swimming pool point 
source outbreaks at recreational aquatic centres in the North Metropolitan area. An additional 
five swimming pool point source outbreaks involving other cases that were not typed were also 
identified. 
This is the first report of the C. hominis IbA12G3 subtype in Australia. Based on dates, 
interviews and subtyping data, it seems possible that the first aquatic centre outbreak, which 
was at a very large centre and included two cases subtyped in the present study, may have been 
the main source, which then spread to the community and other aquatic centres. Next 
Generation Sequencing of the IbA12G3 isolates showed no mixed infections with C. hominis, 
C. parvum and C. cuniculus gp60 subtypes and MLST analysis on a subset of these samples 
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revealed no genetic diversity, suggesting that the same parasite population was responsible for 
the outbreak cases. Due to COVID-19, strict social distancing measures were implemented 
throughout WA in March 2020, which included the closure of all aquatic facilities on the 26th 
of March, 2020. This resulted in a marked reduction in cases, effectively ending the outbreak, 
with levels returning close to baseline by the end of April 2020. 
Interestingly, from 2002 until early 2017 in WA, C. hominis subtype IbA10G2 dominated 
in non-Aboriginal people (Ng et al., 2010a; Ng et al., 2010b; Ng-Hublin et al., 2017; Braima 
et al., 2019), but in 2017, the previously rare C. hominis subtype IfA12G1R5 emerged as the 
dominant subtype (Braima et al., 2019). This subtype (IfA12G1R5) had previously become the 
dominant C. hominis subtype in the US in 2013 and was associated with swimming pool 
outbreaks in Alabama and Arizona (Hlavsa et al., 2017). The reason for the emergence of the 
rare subtypes IfA12G1R5 in 2017 and IbA12G3 in 2020 in WA is unknown, but in the USA 
the swift emergence and transmission of a virulent subtype (IaA28R4) in 2008 was linked to 
dispersal through swimming pools (Feng et al., 2014). It may also be due to the increasingly 
heterogeneous population in metropolitan areas and the transmission of travel acquired 
subtypes (Chalmers et al., 2008; Insulander et al., 2013). The C. hominis IbA9G3 positives in 
the present study were from a 4-year-old male infant and a 37-year-old male, and the single C. 
hominis IeA12G3T3 subtype was from a 13-year-old male with a Salmonella co-infection; both 
are relatively rare subtypes (Ng et al., 2010a; Waldron et al., 2011a; Wang et al., 2013b). 
Subtype IdA19 was linked with a waterpark-associated outbreak in Ohio, USA in 2016 (Hlavsa 
et al., 2017). 
Among the samples analysed in 2020, three mixed IdA15G1/1dA14 infections were 
identified from remote PHUs and one mixed C. parvum IIaA18G3R1/ IIaA16G3R1 co-
infection was identified in a female visitor from Germany. This is the first report of a novel C. 
meleagridis IIIgA23G4R1 variant in two cases, which appear to be unrelated, as both cases 
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were not from the same household and the specimen dates were almost two months apart. One 
of the patients attended a hospital with symptoms of diarrhoea and bloating and had no travel 
history or ill contacts, suggesting the infection may have been acquired locally. 
Cryptosporidium fayeri (subtype IVbA10G1T1R1) identified in a 37-year-old 
immunosuppressed female in the present study, is only the second report of a C. fayeri infection 
in a human host and has been discussed in more detail in Braima et al. (2021). 
The 2020 outbreak was much larger (a rate of 16.2 per 100,000 population for the first two 
quarters) compared to 2019 (annual rate of 7.4 per 100,000 population). In 2019, cases were 
predominantly in remote communities, whereas the 2020 outbreak occurred in metropolitan 
Perth. Molecular analyses also revealed the strikingly different genomic epidemiology between 
the 2019 and 2020 cases, with the small increase in 2019 cases infected with rural and remote 
Aboriginal-population associated C. hominis IdA15G1 subtype and the large outbreak in 2020 
associated with the previously rare C. hominis IbA12G3 subtype.  
To date, four studies have conducted amplicon gp60 NGS of Cryptosporidium-positive 
faecal samples in an attempt to identify low-abundance intra-isolate variants (Grinberg et al., 
2013; Zahedi et al., 2017b; DeMone et al., 2020; Mphephu et al., 2021). In the study by 
Grinberg et al. (2013), NGS analysis of two C. parvum samples from New Zealand identified 
a total of ten gp60 subtypes, compared with two gp60 subtypes by Sanger sequencing. In the 
study by Zahedi et al. (2017b), gp60 amplicon NGS of animal-derived C. hominis (n = 11), C. 
parvum (n = 22) and C. cuniculus (n = 8) samples from Australia and China identified 
additional subtypes in individual C. parvum and C. cuniculus samples (n = 2-4 subtypes), but 
not in C. hominis (compared to the single subtypes identified by Sanger sequencing in all 
samples). More recently, DeMone et al. (2020) developed an 18S NGS amplicon assay 
designed to detect Cryptosporidium spp. and other protozoa in shellfish as a tool for monitoring 
protozoan contamination in food and water. In addition, NGS of 18S and gp60 amplicons was 
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used to identify Cryptosporidium species (C. parvum, C. hominis, C. cuniculus, C. meleagridis 
and C. wrairi) and subtypes (n = 92 corresponding to 22 subtype families) from river water 
and riverbed sediment from the Apies River in South Africa (Mphephu et al., 2021). 
In the present study, the lack of intra-isolate subtype diversity in C. hominis IbA12G3 
cases suggests the recent introduction of this subtype into the WA population. The lack of 
diversity was also confirmed by MLST analyses which may be interpreted as further evidence 
for its recent population expansion in WA and potentially clonal population structure. 
However, further analysis is required to understand the population dynamics and substructure 
of IbA12G3 in WA. In previous studies, MLST analyses at eight loci was used to characterise 
the emergence of C. hominis IaA28R4 as a cause of sporadic and outbreak-related cases in the 
US and at least two origins of IaA28R4 within the United States were identified (Feng et al., 
2014). A more extensive study using 32 MLST markers identified a largely clonal population 
structure for C. hominis IbA10G2 human samples from Peru, which is consistent with most 
previous population studies on C. hominis  (Kváč et al., 2013). 
The findings in the present study have been useful for understanding the transmission of 
Cryptosporidium in WA. The 2019 and 2020 outbreaks were clearly unrelated as they were 
caused by different C. hominis subtypes and both amplicon NGS and MLST analysis support 
the recent introduction of C. hominis IbA12G3 into the WA population. Some of the limitations 
of this study include; the cases subtyped represent only a subset of the WA population.  
Furthermore, only limited contact tracing was conducted on the typed cases to implicate aquatic 
centres in the outbreaks. A larger sampling size, involving more genotyping analysis and 
contact tracing would provide a clearer representation of cryptosporidiosis in the WA human 
population. Routine typing of Cryptosporidium using molecular methods is of public health 
importance. The identification of cryptosporidiosis outbreaks specifically linked to swimming 
pools warrants a more detailed examination of swimming pool filter backwash samples and the 
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knowledge, attitudes and practices of swimming pool patrons to better understand recreational 




5 Knowledge, attitude and practices towards 
Cryptosporidium among public swimming pool patrons 
and staff in Western Australia 
 
 Preface 
The contents of this chapter is under review in Acta Parasitologica (Reviewers assigned: 8 
June 2021 – Manuscript ID: ACTP-D-21-00265.. 
 
Braima K., Harvie S., Trew, I., Tan, H., Gore C., Zahedi A., Oskam C., Lawler S., Reid S., 
Ryan U, 2021. Knowledge, attitude and practices towards Cryptosporidium among public 
swimming patrons and staff in Western Australia. 
 
This chapter describes the knowledge, attitudes and practices of swimming pool patrons and 
staff around public swimming pools in WA. 
Highlights: 
• Swimming pools pose risks for Cryptosporidium transmission and outbreaks 
• Limited knowledge of patrons and staff about risks associated with swimming pools  
• Increased awareness of patrons and staff is necessary to reduce transmission risk  
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 Introduction 
Cryptosporidium is a parasitic protozoan that is mainly transmitted via the faecal-oral 
route and is the leading etiological agent in many recreational water-associated outbreaks 
worldwide (Dale et al., 2010; Hlavsa et al., 2017). Cryptosporidiosis is a notifiable disease in 
Australia, and data indicates that aquatic facilities are a major source of cryptosporidiosis 
outbreaks (Dale et al., 2010; Mayne et al., 2011; Waldron et al., 2011a; Ng-Hublin et al., 2015; 
Efstratiou et al., 2017; Braima et al., 2019; Cullinan et al., 2020). This is mainly due to the 
resistance of the parasite’s environmental stage, the oocyst, to normal chlorine levels used to 
disinfect pools, its very low infectious dose (1–125 oocysts), and small size that render most 
pool filtration systems ineffective in removing oocysts and preventing outbreaks (Amburgey 
et al., 2012; Murphy et al., 2015; Wood et al., 2019). Although ozone and ultraviolet (UV) 
radiation secondary treatments can inactivate Cryptosporidium oocysts, in most cases, they do 
not have a residual effect in the pool and cryptosporidiosis outbreaks are still reported in 
association with ozone and UV treated pools (Boehmer et al., 2009; Ng-Hublin et al., 2015). 
In Australia, hyperchlorination to achieve a free chlorine contact time (CT) inactivation value 
of 15,300 mg-min/L (i.e. free chlorine of 20 mg/L for 13 hours or 10 mg/L for 26 hours) is 
recommended following a diarrhoeal incident and where pools have tested positive for 
Cryptosporidium (Victoria Department of Health, 2020). However, most pools rely on 
coagulation and filtration alone to control cryptosporidiosis outbreaks with variable results 
(Chalmers and Johnston, 2018). 
Assessing the Knowledge, Attitude and Practices (KAP) of both swimming pool patrons 
and staff to determine their understanding of the importance of Cryptosporidium and its 
transmission in swimming pools is an important process to identify shortcomings/gaps in the 
current regulations and procedures in place for the control and prevention of outbreaks. Despite 
this, relatively little research has been conducted on this topic in Australia or worldwide, even 
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though evidence has shown that adherence to disease control measures are substantially 
reduced if community KAP levels are low (Tachfouti et al., 2012; Ajilore et al., 2017; Reuben 
et al., 2020). Therefore, the present study aimed to conduct a KAP survey of public swimming 
pool patrons and staff around the Perth Metropolitan area in Western Australia (WA) to 
determine the (1) knowledge of Cryptosporidium, policy and guidelines, (2) attitudes and (3) 
practices towards Cryptosporidium. 
 Materials and Methods 
5.3.1 Study population and study area 
The survey was conducted in the peak swimming season between the 1st October 2018 
and the 31st of March 2019, and the study population were patrons and staff attending public 
swimming pools in the Perth Metropolitan area, WA. Twelve pool venues located within a 
30km radius of Perth City Centre were approached by telephone and email to participate in the 
study. Selection of the venues was made with the assistance of the Department of Health (WA) 
officers based on whether they were council-owned, preferably offer learn to swim classes and 
were willing to participate in the study. 
5.3.2 Questionnaire design and administration 
Two self-report questionnaires for patrons and staff that were previously developed, 
pre-tested and piloted were used in the present study (Warren, 2017). The questionnaires 
consisted of both open and closed-ended questions and involved four sections related to socio-
demographic characteristics, knowledge, attitudes and practices of Cryptosporidium. Each 
public aquatic facility (PAF) was visited once a week (~2.5 hours) by a team consisting of three 
research members over the study period (October 2018 to March 2019). In each venue, patrons 
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were approached by one of the team members and were asked if they were willing to participate 
in the study. 
5.3.3 Survey delivery and data analysis 
Between the 1st October 2018 and the 31st of  March 2019, the surveys were 
administered using an online web-based SurveyMonkey® platform and/or in hard copy format 
to all patrons and staff present. The pool managers sent their respective staff the online survey 
link to complete the survey electronically. Electronic and hardcopy data was entered into 
Microsoft Excel 365 for Mac (Microsoft, Redmond, WA, USA) to derive the descriptive 
summary data. Data were described descriptively as n (%) for the total respondents. 
Chi-square and Fisher's Exact tests for independence were used to determine the 
associations between patrons and staff responses using R and RStudio (version 1.2.5033). P-
values < 0.05 were considered statistically significant.  
 Results 
5.4.1 Demographic characteristics of the study population 
A total of five venues agreed to participate in the present study, four of which offered 
learn to swim classes (for children aged 5 – 17 years of age). The demographic characteristics 
of the 380 patrons and 40 staff who completed the survey are presented in Table 5.1. The 
majority of patron (75.0%) and staff (62.5%) respondents were female, and most patrons 
(61.6%) and staff (80%) were Australian born (Table 5.1). A larger proportion (80.7%) of 
patrons had a tertiary education compared to staff (40.0%). Data collection in the present study 
coincided with the summer school break between October and January and hence, the majority 
of patrons (n = 315) brought their children for the Government-run swimming lessons 
(VacSwim) 72.5% (n = 267), while 24.2% (n = 89) and 3.3% (n = 12) brought their children 
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for recreational and squad swimming, respectively. Questionnaire data were obtained from 
patrons and staff of all pools except for one pool that did not consent for staff to complete the 
survey. 
 
Table 5.1. Demographic characteristics of swimming pool patrons (n = 380) and staff (n 
= 40) who participated in the knowledge, attitudes and practices (KAP) survey 
associated with Cryptosporidium in metropolitan Perth (2018 – 2019). 
Variable 
Patrons (%) 
n = 380 
Staff (%) 
n = 40 
   
Age 14 – 86 16 – 64 
   
Gender   
   Male 95 (25.0) 15 (37.5) 
   Female 285 (75.0) 25 (62.5) 
   
Country born   
   Australia 234 (61.6) 32 (80.0) 
   Country other than Australia 146 (38.4) 8 (20.0) 
   
Highest qualification   
   High school (Grade 7–12, age 12–18) 50 (19.3) 24 (60.0) 
   Certificate/Diploma/University 209 (80.7) 16 (40.0) 
   # Not applicable 121 0 
   




n = 380 
Staff (%) 
n = 40 
   Yes 315 (82.9) 
n/a 
   No 65 (17.1) 
   
What do you regularly bring your child to this pool for: (please select all 
that apply) 
 
   Swim lessons (e.g. VacSwim) 267 (72.5)  
   Recreational swim 89 (24.2) n/a 
   Squad swimming 12 (3.3)  
   
Pool Demographic   
   Pool A 121 (31.8) 0 (0.0) 
   Pool B 98 (25.8) 8 (20.0) 
   Pool C 96 (25.3) 10 (25.0) 
   Pool D 5 (1.3) 10 (25.0) 
   Pool E 60 (15.8) 12 (30.0) 
   
# – Pool A did not allow the collection of highest qualification from its patrons (n = 121) 
n/a – question not included in the questionnaire 
 
5.4.2 Knowledge of Cryptosporidium  
Knowledge of Cryptosporidium and its transmission among patrons and staff was 
limited. Only about one-quarter of patrons 26.1% (n = 99) had heard of Cryptosporidium and 
only 17.4% (n = 66) were aware that Cryptosporidium can be a causative agent of diarrhoea. 
One-third of patrons 35.8% (n = 136) knew to avoid swimming for two weeks after 
experiencing diarrhoea (Table 5.2). 
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Surprisingly, while 25% (n = 10) of staff had heard of Cryptosporidium, only 10.0% (n = 4) 
were aware that it causes diarrhoea, and only 17.5% (n = 7) of the staff were aware of WA 
Health guidelines to avoid swimming for two weeks after experiencing diarrhoea (Table 5.2). 
 
Table 5.2. Participant responses on the knowledge, policy and guidelines and pool 
environment towards Cryptosporidium in metropolitan Perth (2018 – 2019). 
Variable Patrons 
(%) 
n = 380 
Staff (%) 
n = 40 
Knowledge of Cryptosporidium and transmission   
Have you ever heard of Cryptosporidium?   
   Yes 99 (26.1) 10 (25.0) 
   No 281 (73.9) 30 (75.0) 
   
Do you know what illness Cryptosporidium can cause? (please select all 
that apply) 
  
   Diarrhoea 66 (17.4) 4 (10.0) 
   Symptoms Other than diarrhoea (chest infection/head cold/flu) 314 (82.6) 36 (90.0) 
   
According to WA Health guidelines, what is the recommended length of 
time to avoid swimming after experiencing diarrhoea? 
  
   2 weeks after my last bout of diarrhoea 136 (35.8) 7 (17.5) 
   48 hours after my last bout of diarrhoea 241 (63.4) 14 (35.0) 
   I don’t know 3 (0.8) 19 (47.5) 
   
Knowledge of pool policy & guidelines   




n = 380 
Staff (%) 
n = 40 
   Yes, they have a policy - proceed to next question 119 (31.3) 25 (62.5)* 
   No / I don't know 261 (68.7) 15 (37.5) 
   
What is your pool policy if you have diarrhoea? Patrons N=119 N=25 
   I can re-enter the pool 2 weeks after my gastroenteritis symptoms have 
resolved 
0 (0.0) 4 (16.0%)* 
   I must stay out of the water for at least 1 week after gastroenteritis 
symptoms resolved 
119 (100.0) 21 (84.0%) 
   Not Applicable (proceeded to Q27 onwards - 261) n/a n/a 
   
What is your pool’s policy if your child has diarrhoea?  N = 315  
   My child can re-enter the pool 2 weeks after their gastroenteritis 
symptoms have resolved 
8 (2.5) n/a 
   My child must stay out of the water for at least 1 week or after 
gastroenteritis symptoms resolve 
307 (97.5)  
   Not Applicable (No child) 65 (n/a)  
   
Does your pool have an illness policy if your child misses swimming 
classes due to illness?  
N = 315  
   Yes 96 (30.5) n/a 
   No 33 (10.5)  
   I don’t know 186 (59.0)  
   Not Applicable (No child) 
 
65 (n/a)  
What is your pool policy in relation to payment if your child must miss 
a swimming class due to gastroenteritis? 




n = 380 
Staff (%) 
n = 40 
   I don’t pay for classes missed 10 (3.2) n/a 
   We can do makeup lessons 47 (14.9)  
   We forfeit our fee for that week 55 (17.5)  
   There is no policy in relation to gastroenteritis and swim classes 14 (4.4)  
   I don’t know / Other reason 189 (60.0)  
   Not Applicable 65 (n/a)  
   
Knowledge of pool environment   
There is signage at my pool regarding showering before entering the 
water 
  
   Yes 116 (30.5) n/a 
   No / I don’t know 264 (69.5)  
   
There is signage at my pool regarding illness policy and swimming   
   Yes 78 (20.5) n/a 
   No / I don’t know 302 (79.5)  
   
There are brochures available at my pool regarding illness policy and 
swimming 
  
   Yes 66 (17.4) n/a 
   No / I don’t know 314 (82.6)  
   
There are showers available at the side of the pool   
   Yes 188 (49.5) n/a 
   No / I don’t know 192 (50.5)  
n/a – question not included in the questionnaire  
*Significant association (P < 0.05). 
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5.4.3 Knowledge of policy and guidelines 
Knowledge of policy and guidelines varied significantly between patrons and staff (p-
value < 0.001). Less than one-third 31.3% (n = 119) of patrons were aware of their aquatic 
facility’s policy regarding diarrhoea and swimming, whereas 62.5% (n = 25) of the staff were 
aware. Among the proportion of patron respondents (n = 119), all were unaware of their pool 
policy to avoid entering the pool for at least two weeks (n = 0) after their diarrhoeal symptoms 
had cleared as compared to 16.0% (n = 4) of staff (p-value < 0.001, Table 5.2). 
Among patrons with children (n = 315), only 2.5% (n = 8) were aware that their children should 
not re-enter the pools for at least two weeks after their diarrhoeal symptoms had cleared, 
whereas 97.5% (n = 307) thought that one week was sufficient. Sixty-five respondents without 
children did not provide a response to this question. Furthermore, more than half of patrons 
(59.0%) were unaware of their aquatic facility’s illness policy in the event of their child missing 
swimming classes due to illness, and a similar proportion were unaware 60.0% (n = 189) of 
their pool’s policy concerning swimming class fee refunds if their child missed a swimming 
class due to illness (Table 5.2). 
5.4.4 Knowledge of pool environment 
Patrons' knowledge of pool environment that related to signage was also limited, with 
only 30.5% (n = 116) of respondents aware of signage regarding showering, and illness and 
swimming 20.5% (n = 78). Only 17.4% (n = 66) of patrons were aware of information about 
brochures that provided information on the pool’s illness policy and swimming, and 49.5% (n 
= 188) of patrons were unaware of the availability of showers beside the pools (Table 5.2). 
5.4.5 Attitudes towards gastroenteritis and Cryptosporidium 
Patrons and staff attitudes towards gastroenteritis and Cryptosporidium are reported in 
Table 5.3. Thirty-five percent of patrons (n = 135) and 37.5% of staff (n = 15) believed that 
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showering before entering a pool reduced gastroenteritis. Only a small number (6.3%, n = 24) 
of patrons thought that alcohol-based hand sanitizers inactivated Cryptosporidium, but the 
majority 87.4% (n = 332) were unaware. Almost all patrons (96.8%, n = 368) felt that children 
with diarrhoea should not be allowed to swim in a pool (Table 5.3). The latter two questions 
were not included in the staff questionnaire. 
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Table 5.3. Attitudes of patrons and staff towards gastroenteritis and Cryptosporidium 
around public swimming pools in metropolitan Perth (2018 – 2019) 
Variable Patrons 
(%) 
n = 380 
Staff (%) 
n = 40 
   
Do you think showering before entering a swimming pool 
reduces the risk of gastroenteritis? 
  
   Yes 133 (35.0) 15 (37.5) 
   No 176 (46.3) 13 (32.5) 
   I don’t know 71 (18.7) 12 (30.0) 
   
Do you believe that alcohol-based hand gels and sanitizers 
effectively inactivate Cryptosporidium? 
  
   Yes 24 (6.3)  
   No 24 (6.3) n/a 
   I don’t know 332 (87.4)  
   
Do you think that children with diarrhoea should be allowed to 
swim in a pool? 
  
   Yes, if they have aqua-nappies / or are toilet trained 12 (3.2) n/a 
   No 368 (96.8)  
   
n/a – question not included in the questionnaire 
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5.4.6 Practices of patrons with children towards Cryptosporidium 
Table 5.4 shows the results of parents' practices associated with diarrhoea and the risk of 
infection with Cryptosporidium. A total of 14.7% (n = 56) of parents surveyed had at least one 
of their children that had used the pool despite having diarrhoea within the previous two weeks. 
Only half of the patrons surveyed 49.3% (n = 212) responded that they would notify pool staff 
if their child had an accidental faecal release (AFR) in the pool. 
 




n = 380 
Staff (%) 
n = 40 
   
When was the last time your child had diarrhoea?  N = 315  
   Less than 2 weeks 56 (14.7) n/a 
   2 weeks ago 175 (46.1)  
   More than 2 weeks / I don’t remember 84 (22.1)  
   Not applicable (No child) 65 (17.1)  
   
Parents actions if children have an AFR in the pool (please select 
all that apply) 
  
   I notify a pool staff 212 (49.3) n/a 
   I take my child out of the water and change their nappy 143 (33.3)  
   I leave it with pool staff to take action 72 (16.7)  
   I leave my child in the pool 3 (0.7)  
n/a – question not included in the questionnaire 
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 Discussion 
This is the first study to assess the KAPs of public swimming pool patrons and staff in 
WA and a poor understanding of Cryptosporidium and how to limit its spread was revealed. 
Indeed, only 26.1% and 25.0% of patrons and staff respectively had heard of Cryptosporidium 
and that only 35.8% of patrons and 17.5% of staff correctly identified that swimming should 
be avoided for at least two weeks after experiencing diarrhoea. A previous study reported a 
third (33.3%) of swimming pool patrons and 80% of staff in Queensland were aware of 
Cryptosporidium and how it is transmitted (Warren, 2017). However, in that pilot study, the 
sample size was smaller with only 34 patrons and 4 employee respondents completing the 
questionnaires (Warren, 2017). A study in Nebraska found that 32% of patrons continued to 
swim despite being ill or within two weeks of experiencing diarrhoea (CDC, 2001). Similarly, 
a study in the US reported that only a quarter of parents were aware that children should abstain 
from swimming for at least two weeks following cessation of diarrhoeal symptoms (Munoz et 
al., 2016). Even if patrons adhere to this, it still may not prevent the transmission of 
Cryptosporidium in all cases. This is because Cryptosporidium oocyst shedding post-cessation 
of diarrhoea is very variable and can extend for up to 60 days (Jokipii and Jokipii, 1986; Stehr-
Green et al., 1987). 
The lack of knowledge regarding Cryptosporidium and its transmission amongst staff is 
concerning because pool staff have been identified as the source of cryptosporidiosis in 
previous outbreaks (Sorvillo et al., 1992; Bell et al., 1993; Louie et al., 2004; Ng-Hublin et al., 
2015). Indeed, the study by Ng-Hublin et al. (2015) showed that a cryptosporidiosis outbreak 
in WA was linked to a swimming instructor who continued to swim at the pool despite having 
diarrhoea and being advised by their doctor not to swim. 
The poor knowledge of pool policies and safe pool guidelines among patrons compared 
to staff is important as it may be evidence of suboptimal implementation of the WA Department 
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of Health’s Guidelines for Recreational Water Quality (WA Department of Health, 2015). 
Although 62.5% of staff respondents stated that they had good knowledge of their facility 
policy and guidelines, only 16.0% knew the critical fact regarding re-entering the pool after 
two weeks of Cryptosporidium infection. In addition, the majority of patrons were unaware of 
their pool policy concerning payment if their child missed a swimming class. Although there 
are no studies exploring the impact of payment policies regarding Cryptosporidium infections 
and swimming, financial issues can be barriers to policy compliance. Make-up swim lessons, 
cancellation and refund policies should be encouraged to prevent children with diarrhoeal 
illness from entering the pool. 
It is noteworthy that most patrons in the present study were unaware of the location and 
availability of signage, brochures and showers around the swimming pool venues. This is 
important as a study by Gerba (2000) estimated that on average individuals will shed 0.14g of 
faeces during water contact and up to 10g of faeces can be shed. The observation that there was 
no significant difference in the responses of patrons born in and outside Australia regarding 
their knowledge of signage and illness available at the pools (p-value = 0.6037) contrasts with 
other studies (Cullinan et al., 2020). This is interesting because a substantial proportion of 
patrons and staff were not born in Australia and as signage and brochures available at pools 
were printed in English. The level of English literacy has previously been identified as a 
communication barrier in a study in Victoria (Cullinan et al., 2020), so consideration of the 
language of communication of health messages is an important consideration. However, it is 
difficult to interpret this finding because the study did not include more detailed data on country 
of origin or duration of residency in Australia, which would impact on English literacy. 
Furthermore, the majority of respondents possessed a tertiary qualification, which may be 
associated with a higher than average level of English literacy. Although, it is worth noting that 
both groups had poor knowledge of pool signage suggesting that the language barrier is less 
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important, a more extensive study that included more linguistically diverse populations would 
be needed to explore this issue further. 
Alcohol-based hand gels and sanitizers are ineffective against Cryptosporidium spp. and 
have been previously identified as risk factors in cryptosporidiosis outbreaks (Yoder et al., 
2010; Gormley et al., 2011). In this study, 87.4% of patrons are unaware that alcohol-based 
hand gels do not inactivate Cryptosporidium. However there are reports of the use of alcohol-
based hand gels and sanitizers prior to cryptosporidiosis outbreaks as a primary method of hand 
hygiene  with little impact on transmission (Gormley et al., 2011; Hancock‐Allen et al., 2017). 
The Centers for Disease Control (CDC) recommends practising good hand hygiene measures 
(i.e., washing hands with soap and water for at least 20 seconds) to limit the spread of 
Cryptosporidium. Thus, studies that look into handwashing facilities and their use in these 
venues should be explored. 
Only 3.2% of patrons thought it was acceptable for children with diarrhoea to swim in a 
pool if they had aqua nappies or were toilet trained. A previous study that used 
Cryptosporidium-sized microspheres as a surrogate for Cryptosporidium oocysts reported that 
nappy-aged children released 100% of microspheres in disposable swim nappies within 10 min 
of play in water bodies (Amburgey and Anderson, 2011). Despite the current recommendations 
to avoid swimming for at least two weeks following diarrhoeal symptom resolution (WA 
Department of Health, 2019), it is concerning that about a quarter of patron’s children had 
diarrhoea in the previous two weeks at the time of completing the survey. It is also concerning 
that more than half of patrons would not notify a pool staff if their children had an AFR in the 
pool. There needs to be greater awareness of the need to respond to AFRs and possibly 
interventions to support parents do the right thing. 
Further studies need to develop and evaluate intervention strategies for improving 
knowledge and hygiene practices of patrons and staff are required to reduce the burden of 
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Cryptosporidium infections in aquatic environments. Regulators of aquatic facilities need to 
ensure staff are adequately trained and that policies associated with patron behaviour are 
enforced in their routine audits of aquatic facilities. Future intervention studies to improve AFR 
reporting by patrons and targeting staff regarding policies not to attend work if they have had 
diarrhoea within two weeks and/or alternative "dry" duties which would exclude them from 
the water body and clear guidelines on whether they can take sick/personal leave for two weeks 
post symptoms should also be explored. 
In conclusion, the findings of the present study provide further evidence that there is a 
lack of knowledge and hygiene measures by both patrons and staff about Cryptosporidium and 
to prevent gastroenteritis transmission in swimming pools. This knowledge gap increases the 
risk of an infectious patron (or staff member) unknowingly introducing Cryptosporidium in 
aquatic facilities. Health promotion activities to improve patrons and staff KAP are essential. 
Also, clear and well-disseminated policies to encourage children to be kept home for two weeks 




6 Lack of detection of Cryptosporidium in swimming 
pool filter backwash samples using calcium 




This work has been prepared as a thesis chapter. 
This chapter describes the testing of swimming pool filter backwash and balance tank water 




Cryptosporidium is an important cause of cryptosporidiosis outbreaks associated with 
swimming pool venues in Australia and other developed nations (Efstratiou et al., 2017; Ryan 
et al., 2017a; Gracenea et al., 2018). The most common cause of recreational water outbreaks 
is faecal accidents, whereby patrons can become infected with Cryptosporidium after ingestion 
of infectious oocysts shed by infected bathers due to accidental faecal releases (AFR) or lack 
of and/or inadequate showering prior to entering the pool (Wiant, 2012; Pasquarella et al., 
2013; Ryan et al., 2017a). To mitigate these risks, swimming pools routinely employ both 
filtration and chlorination to help control Cryptosporidium (Wood et al., 2019).  
Sand and cartridge filters are the most commonly used filters, even though their removal 
rate for Cryptosporidium is poor (Amburgey et al., 2012; Ryan et al., 2017a). Lack of good 
practices in pool management resulting in differences in residual chlorine levels also impact 
the efficiency of water disinfection by free residual chlorine (Wei et al., 2018).  In addition to 
chlorination, UV light irradiation (Hijnen et al., 2006) and ozone (Korich et al., 1990) are 
effective secondary treatments to inactivate Cryptosporidium oocysts. However, these methods 
do not provide a residual for disinfection of swimming pool water, and outbreaks of 
cryptosporidiosis associated with swimming have still been reported from well-maintained 
pools using secondary disinfection (Boehmer et al., 2009; Ng-Hublin et al., 2015; Ryan et al., 
2017a).  
Studies assessing Cryptosporidium in swimming pools are limited as investigation of 
water samples from backwash, balance tanks and source water in WA is not required unless a 
cryptosporidiosis incident or outbreak investigation is being conducted (WA Department of 
Health, 2020). Hence, no data exists on the occurrence of Cryptosporidium in pools in the 
absence of outbreaks. Indeed, detection of faecal contamination of human or animal origin in 
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aquatic venues is generally undertaken by testing for the presence of E. coli (WA Department 
of Health, 2020). 
Routine sampling of water to test for the presence of Cryptosporidium may be a more 
direct measure of human risk and assist in identifying non-compliance with water quality 
guidelines. The use of filter backwash as a sample for screening may increase the sensitivity 
of detection and reduce costs compared to bulk water sampling to screen for Cryptosporidium 
oocysts. Hence, the present study is designed to evaluate the feasibility of using filter backwash 
as a screening medium in public swimming pools and splash parks water in the Perth 
Metropolitan area in WA.  
 Materials and Methods 
6.3.1 Aquatic venue data collection 
A total of 32 swimming pool filter backwash and balance tank water samples were 
collected from six aquatic facilities (Pools A-D and Splash Parks SPA-SPB) within a 30km 
radius of Perth City Centre, WA between 1st October 2019 and the 31st of March 2020. Aquatic 
venue data (UV usage, type of pool and type of filtration) were recorded. The pools varied 
from each other in terms of UV usage (Pools C and D), type of pools (learn to swim (Pool A, 
B, D), or lap/sporting club pool (Pool C), filtration types and filter backwash collection site. 
Three of the swimming pools (A, B and C) and both splash parks used sand filters, and one 
pool (D) utilised Neptune Benson Defender filters (Table 6.1).  
6.3.2 Filter backwash sample collection  
Table 6.1 summarises the characteristics of swimming pools in the present study. Filter 
backwash samples (n = 26) were obtained from Pools A, B, C and D, while splash park water 
samples (n = 6) were obtained from balance tanks (Table 6.1). The water samples were 
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collected in 10-litre containers from the filter backwash drain line/backwash pits or directly 
from balance tanks of each pool with assistance from trained pool staff. The filter backwash 
valve was located at the filter backwash drain line that leads to the filter backwash pit. Briefly, 
the pump to the filter was turned off, followed by closing the return to pool valves. The 
multiport valve was opened to redirect water from the bottom to the top of the filter to loosen 
all debris. The pump was then started for approximately 2-3 minutes (or until the filter 
backwash water become clear) to allow for water to backwash the filter and pump the debris 
to the backwash pit/tank. The pump was turned off, and the multiport valve was closed. The 
filter backwash was then collected through a backwash water outlet before the return to pool 
valves were opened, and the pump was re-started to continue filtering pool water. The samples 




Table 6.1. Swimming pools and splash parks screened in the present study. 






Pool A Learn to 
swim 
Sand filter Chlorine None Filter backwash 
and backwash pit 
(n = 6) 
Pool B Learn to 
swim 
Sand filter Chlorine None Filter backwash 
and backwash pit 
(n = 8 ) 
Pool C Lap/sporting 
club pool  
Sand filter Chlorine UV Filter backwash (n 
= 8) 





Chlorine UV Filter backwash (n 
= 4) 
Splash Park A  Spray Pad Sand filter Chlorine None Balance tank (n = 
3) 
Splash Park B Spray Pad Sand filter Chlorine None Balance tank (n = 
3) 
 
6.3.3 Calcium carbonate flocculation, immunomagnetic separation and qPCR analysis  
All 10-litre filter backwash samples were initially concentrated using calcium carbonate 
flocculation (CCF) according to the protocol by Vesey et al. (1993) with slight modifications. 
Following flocculation, immunomagnetic separation (IMS) was carried out using 
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Cryptosporidium-specific antibody-coated magnetic beads (Dynabeads™ anti-
Cryptosporidium kit, Applied Biosystems), following the manufacturer’s protocol. The 
resulting IMS supernatant was subjected to DNA extraction using a DNeasy Power Soil DNA 
Isolation Kit (QIAGEN, Carlsbad, California, USA) following the manufacturer's instructions 
with modifications as described by Ng-Hublin et al. (2013b). 
Positive control spikes (n = 4) were 10-litre deionised-water spiked with approximately 
~100 commercial C. parvum oocysts that were diluted from a 108 oocysts per ml stock solution 
(Iowa strain) (BioPoint Pty Ltd, Sydney, Australia). Prior to spiking, the oocysts were counted 
using a haemocytometer and quantified by droplet digital PCR (ddPCR) using a ddPCR 
protocol previously described (Yang et al., 2014). Extraction reagent blanks were used as 
negative controls. The extracted DNA was stored at −20°C prior to qPCR analysis. 
The DNA samples were screened for Cryptosporidium at the 18S rRNA locus using a 
quantitative PCR (qPCR) on a Rotorgene (Qiagen) as previously described (King et al., 2005; 
Yang et al., 2014), but using dilution standards that had been quantified using ddPCR. No-
template controls (NTC) and 1 μL of template DNA was used in all qPCR reactions. PCR 
inhibition analysis using samples spiked with positive control DNA (neat, 1:5 and 1:10 
dilutions) were used to rule out PCR inhibition. 
 Results 
A total of 32 filter backwash and balance tank water samples were processed and 
examined for the presence of Cryptosporidium oocysts during a 6-month period (October 2019 
- March 2020). Cryptosporidium spp. were not detected in the 32 screened 10-litre filter 
backwash and balance tank water samples by qPCR. Digital droplet PCR (ddPCR) determined 
that there were 110.7 oocysts spiked into each control. C. parvum (Iowa strain) spike controls 
(n = 4) recovery from the 10-litre deionised water ranged from 7.3 to 23.6 oocysts (Table 6.2). 
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A representative spike C. parvum (Iowa strain) control was sequenced at the 18S to confirm 
that the qPCR postives were true positives. PCR inhibition testing using samples spiked with 
neat, 1:5 and 1:10 dilutions of positive control DNA indicated no PCR inhibition was 
occurring. 
 
Table 6.2. Recovery rates for C. parvum (Iowa strain) positive control oocysts spiked into 
10L of deionised water. 




1 26 23.6 
2 17 15.5 
3 9 8.2 
4 8 7.3 
Mean recoveries = 15 oocysts (13.6%). 
Average haemocytometer-counted spiked C. parvum (Iowa strain) oocysts enumerated by 
ddPCR ~ 110.7 oocysts. The 10-litre deionised water were spiked and oocysts were extracted 
using calcium carbonate flocculation and IMS. 
*based on a spike count of 110 oocysts determined by ddPCR 
 Discussion 
Backwashing is a cleaning process to remove accumulated debris (including 
Cryptosporidium oocysts) trapped in the filter and involves reversing the flow of water through 
the filter and directing the debris to waste (Murphy et al., 2018). Pool backwash therefore 
potentially contains concentrated microbes and backwash screening has been used successfully 
to detect Cryptosporidium in pools (Shields et al., 2008; Ehsan et al., 2015; Murphy et al., 
2018; Pineda et al., 2020). However, in the present study, Cryptosporidium spp. were not 
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detected in the 32 screened filter backwash and balance tank water samples during the study 
period. This may be due to two factors. Firstly, there may have been no oocysts present. 
Secondly, oocysts may have been present but were lost during sample collection, or were 
present but the DNA extraction and amplification processes were unsuccessful. 
A major issue encountered during the sample collection was the difficulty in obtaining 
the initial backwash samples once the backwash process had started. The reason for this was 
the high water-pressure in the backwash water outlet created by the backwash pump during the 
filter backwash process. Samples could only be collected once the pump was turned off and 
the backwash water pressure returned to normal. As a consequence, it was several minutes 
before the backwash sample could be collected, meaning that the majority of debris (and 
potentially oocysts) from the filter backwash was not captured. The splash park samples were 
obtained directly from balance tanks, which overcame this issue. However, these samples were 
also negative. Little information is available regarding the collection of backwash samples 
from the literature, but previous studies have reported collection of samples within 30 seconds 
of initiation of backwash discharge (Hutcheson et al., 2013; Murphy et al., 2018), which would 
greatly increase the chances of detecting any oocysts that may be present in the backwash.  
Varying prevalences of Cryptosporidium in swimming pool backwash samples have 
been reported in the literature. For example, two studies in Atlanta Georgia reported 
prevalences ranging from 0.6% (1/161) to 1.2% (2/160) (Murphy et al., 2018). A study in the 
Netherlands reported a prevalence of 4.6% (7/153), including viable infectious oocysts in a 
learner pool (Schets et al., 2004) and in Belgium, a prevalence of 5.4% (2/37) was recorded 
(Ehsan et al., 2015). The highest prevalence was reported in Barcelona pools at 18.8% (6/32) 
(Gracenea et al., 2018), followed by Brazil at 9.5% (2/21) (Pineda et al., 2020). Another study 
in Greece, which screened between 500-1000L of pool water directly from three separate 
samples from three different pools, detected Cryptosporidium in one sample at a concentration 
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of 0.3 oocysts per litre (Karanis et al., 2002). A later study in Greece which screened 462 pool 
water samples over an 8 year period did not detect Cryptosporidium oocysts in five different 
types of swimming pools (Papadopoulou et al., 2008). 
The majority of these studies used concentration methods based on the United States 
Environmental Protection Agency (USEPA) method 1623 (USEPA, 2005) that involves 
filtration followed by IMS. In the present study, 10-litre calcium carbonate flocculation 
followed by IMS was used. Calcium carbonate flocculation has been widely used for the 
recovery of Cryptosporidium from water matrices (Vesey et al., 1993; Skerrett and Holland, 
2000; Feng et al., 2011a; Andreoli and Sabogal-Paz, 2021) and has the advantage of being 
much more cost effective and efficient in turbid samples (Vesey et al., 1993; Feng et al., 2011a). 
In the initial publication by Vesey et al. (1993), recoveries of oocysts from seeded samples of 
deionized, tap and river water were in excess of 68%. 
Calcium carbonate flocculation coupled with IMS has also previously been evaluated for 
the recovery of Cryptosporidium oocysts from pool backwash samples and shown to be 
effective with mean recoveries of 21.7% of oocysts (Greinert et al., 2004), while in the study 
by Gracenea et al. (2018), mean recovery efficiencies of 65% were reported. 
In the present study, Cryptosporidium oocyst recovery data from spiked controls 
revealed low recoveries ranging from 7.3 to 23.6% with a mean recovery of 13.6%, although 
sequencing confirmed that the qPCR positives were true positives. This low recovery rate 
coupled with the logistical issues in collecting backwash due to the high filter backwash water 
pressure, meant that potentially backwash debris containing oocysts was not captured. PCR 
inhibition testing suggested that PCR inhibition was not a factor.  An additional reason for the 
lack of oocyst detection in the present study may have been due to random sampling of filter 
backwash samples in the absence of reported accidental faecal releases (AFRs). Future testing 
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could focus on testing pools in which AFRs were recently reported, however in practice this is 
difficult as pools are often reluctant to report AFRs. 
In conclusion, in the present study, Cryptosporidium was not detected in 32 samples of 
swimming pool filter backwash and balance tank water collected from the Perth Metro area in 
WA. A more efficient sampling strategy for pool water may increase the chances of detecting 
Cryptosporidium in pool water. Similarly more studies on standardising recovery rates of 
Cryptopsoridium oocysts from flocculation and IMS need to be conducted. A more 
standardised method of backwash sampling and oocyst recovery coupled with molecular 
detection and typing will provide useful information for source attribution in outbreak 
investigations and epidemiological studies. This information will provide a more robust 
evidence base for the role pools play in Cryptosporidium transmission and the subsequent 




7 General discussion 
 
 Introduction 
Cryptosporidium is the leading cause of recreational water-associated outbreaks, 
particularly associated with aquatic facilities and is the second most important cause of 
moderate to severe diarrhoea in children under five years of age. This thesis was a 
multidisciplinary approach that investigated community and swimming pool associated 
gastroenteritis outbreaks of cryptosporidiosis in Western Australia (WA), caused by the 
parasite Cryptosporidium, with particular emphasis on molecular epidemiology and 
questionnaire data. 
Prior to this research, little was known about the epidemiology of cryptosporidiosis in 
swimming pools, and patron and staff’s KAP levels in relation to behaviours and attitudes 
towards Cryptosporidium in swimming pools in WA. The studies reported in this thesis 
provided updated epidemiological information on Cryptosporidium infections occurring in 
WA and explored tools to improve detection in pools and risk mitigation programs in order to 
develop recommendations for improved management and control of cryptosporidiosis in 
swimming pools. 
 The emergence of rare Cryptosporidium subtypes in swimming pool outbreaks 
The emergence of unusual subtypes that cause cryptosporidiosis outbreaks in various 
countries are increasingly being identified. Prior to the findings in the present study, the 
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dominant C. hominis IbA10G2 subtype was previously implicated in the majority of sporadic 
and outbreak C. hominis-associated cryptosporidiosis cases in Europe (Chalmers et al., 2018), 
and among non-Aboriginal human populations in Australia (Ng-Hublin et al., 2018). This 
subtype was also the cause of a massive outbreak in Milwaukee, Wisconsin, USA in 1993, 
where an estimated 400,000 individuals became infected through contaminated drinking water 
(Zhou et al., 2003; Xiao, 2010). 
In both the outbreaks typed in the present thesis, the emergence of the relatively rare C. 
hominis IfA12G1R5 and IbA12G3 subtypes that were spread through swimming pools is 
alarming as swimming pools are a popular location for recreational activities, with the majority 
of Cryptosporidium outbreaks linked to swimming pools and aquatic venues (Ryan et al., 
2017a). Although it was previously reported that C. hominis IfA12G1R5 emerged as the 
dominant C. hominis subtype among sporadic and outbreak-associated cases in the USA 
(Hlavsa et al., 2017), the reasons for the emergence of both C. hominis subtypes in the present 
study are unknown. Feng et al. (2014) identified that genetic recombination was a driving force 
in the emergence and transmission of the virulent C. hominis subtype IaA28R4 in the US, 
which was amplified through swimming pools. In other countries such as the UK, rare C. 
hominis subtypes such as IaA14R3, IbA12G3, IbA6G3, IdA16, IdA25 and the C. parvum 
subtype IIaA26G1R1 have all been identified as the cause of swimming pool outbreaks (Xiao 
and Feng, 2017; Chalmers et al., 2019). 
The emergence of Cryptosporidium subtypes that can be easily transmitted through 
swimming pools highlight the need for routine surveillance and identification of 
Cryptosporidium at the species and subspecies level to understand the sources of infections 
and gauge the impact on public health in outbreaks (Chalmers et al., 2018). For example, in 
Sweden, molecular typing identified that the majority of travel-related cryptosporidiosis cases 
were due to C. hominis (Lebbad et al., 2021). In the UK, infection with a non-C. hominis 
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IbA10G2 subtype was significantly linked to recent travel outside Europe (Chalmers et al., 
2008). In a study by Elwin et al. (2012b), although the majority of typed cryptosporidiosis 
cases in the UK between 2000-2008 were due to C. hominis and C. parvum, 41% of cases due 
to other species and genotypes (n = 109) had travelled abroad, mainly to the Indian 
subcontinent, with travel abroad a significant risk factor (P<0·01) associated with C. 
meleagridis in particular (Elwin et al., 2012b).  
Similarly, a recent cryptosporidiosis outbreak linked to swimming pool exposure in 
Scotland identified multiple Cryptosporidium species and subtypes including the rare C. 
hominis IbA6G3 subtype, which had not been previously been reported in the UK (Polubotho 
et al., 2021). Importantly, in that study, the only case which had reported recent foreign travel 
was the index case, which was identified as IbA6G3 (Polubotho et al., 2021). Thus, imported 
cases from travellers can be a major contributor to the introduction of unusual Cryptosporidium 
species and subtypes into countries, which can then be spread and amplified by swimming 
pools. 
 Zoonotic transmission of cryptosporidiosis  
Human encroachment into wildlife-populated areas has seen the detection and 
emergence of human infections with a number of Cryptosporidium species and genotypes that 
were thought to be host-specific (Zahedi et al., 2016). Evidence of zoonotic infection by a 
marsupial-associated Cryptosporidium species was reported in Chapter 3, which indicated the 
potential of spillover of zoonotic pathogens to humans and further highlighted the importance 
of routine molecular typing, in contrast to microscopy and/or PCR detection methods currently 
routinely employed in WA. This spill over of wildlife species has also been seen in other 
countries. For example, C. ubiquitum and Cryptosporidium chipmunk genotype I that infect 
wildlife are currently considered emerging human pathogens in many countries (Insulander et 
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al., 2013; Lebbad et al., 2013; Li et al., 2014; Guo et al., 2015). Whole Genome Sequencing 
(WGS) studies have shown that chipmunk genotype I possesses metabolic pathways and 
invasion-related proteins similar to those in C. parvum, C. hominis and C. meleagridis (Xu et 
al., 2019), which supports its ability to infect humans. 
Similarly, many wildlife species adapt successfully to urban environments resulting in 
more interactions with humans. For example, the brushtail possum (Trichosurus vulpecula) is 
one of the most abundant native marsupials in urban Australia (Hill et al., 2008) and although 
the relatively few possums screened to date have mostly been infected with the host adapted 
possum genotype, they can also shed C. parvum and C. hominis oocysts (Hill et al., 2008). The 
detection of C. fayeri in humans in the present study, highlights our lack of knowledge about 
the human infectious potential of many species and genotypes of Cryptosporidium infecting 
wildlife. It also indicates the need for routine genotyping of human cases of cryptosporidiosis 
to identify occurrences of zoonotic transmission, particularly those associated with wildlife.  
Identification of marsupial-associated species in humans suggests that more regular 
monitoring of drinking water catchments is needed as they are more likely to be contaminated 
by wildlife-associated Cryptosporidium species. Several studies have reported the presence of 
zoonotic Cryptosporidium species in faecal samples of animals inhabiting water catchments 
and reservoirs across several states in Australia (Koehler et al., 2016; Zahedi et al., 2018). 
Another study reported significant increases in oocyst concentrations after a rainfall event in 
South Australia indicating that Cryptosporidium oocysts in faecal samples deposited in 
catchments are transported into source waters due to rainfall run-off (Swaffer et al., 2014). 
Analysis of Cryptosporidium monitoring data of source water across Australia over a period of 
11-18 years by Water Research Australia (WaterRA) revealed that detection of total (i.e. 
presumptive) Cryptosporidium ranged from 2-7% in NSW, ~ 15% in Melbourne and Canberra 
to ~ 20% of samples from South Australia and WA (Deere et al., 2014). 
 99 
 Cryptosporidium genotyping for surveillance of sporadic and outbreak 
investigations 
Since the establishment of the National Notifiable Disease Surveillance System 
(NNDSS) in Australia in 1990, cryptosporidiosis outbreaks are regularly reported. However, 
molecular identification of Cryptosporidium in Australia is conducted on an ad-hoc basis by 
individual researchers and no national Cryptosporidium reference laboratory exists. This 
contrasts with government organisations such as Centers for Disease Control (CDC) in the 
USA, which developed CryptoNet in 2010, a molecular-based surveillance system that 
distinguishes species and subtypes of all notified Cryptosporidium cases  
(https://www.cdc.gov/parasites/crypto/cryptonet.html) (Hlavsa et al., 2017). Using CryptoNet, 
molecular typing of Cryptosporidium cases is integrated with traditional epidemiologic data to 
provide further insight into possible Cryptosporidium exposures and sources of outbreaks in 
the United States (Fill et al., 2017; Hlavsa et al., 2017). CryptoNet allowed the identification 
of chains of transmission for Cryptosporidium including the emergence of the C. hominis 
IfA12G1R5 subtype in swimming pool-associated outbreaks in Alabama and Arizona and the 
implementation of evidence-based prevention strategies (Hlavsa et al., 2017). Similarly, in the 
UK, the Cryptosporidium Reference Unit (CRU) (www.gov.uk/guidance/cryptosporidium-
reference-unit-cru) in Swansea routinely type all notified Cryptosporidium cases since 2000 
and has been key to the identification of swimming-pool associated outbreaks of 
cryptosporidiosis (Chalmers et al., 2019). 
In 2014, the European Centre for Disease Prevention and Control (eCDC) identified a 
“need to better understand the epidemiology of cryptosporidiosis in the EU/EEA through 
increased laboratory testing and speciation/sub-typing of isolates” (European Centre for 
Disease Prevention and Control, 2014). Routine typing of Cryptosporidium is now conducted 
in France, Germany, The Netherlands, Norway, Spain and Sweden to supplement 
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Cryptosporidium surveillance and to assist outbreak investigations and a harmonised multi-
locus genotyping scheme is being developed (Chalmers et al., 2018). The establishment of a 
government supported Cryptosporidium reference laboratory to routinely type all notified 
cryptosporidiosis cases in Australia would be used to monitor the emergence and spread of 
sporadic and outbreak Cryptosporidium infections and identify the contribution of zoonotic 
and overseas travel related infections involved in the transmission of Cryptosporidium across 
Australia and would greatly facilitate prevention strategies in outbreak settings including 
swimming pools. 
 Swimming pool filter backwash testing for Cryptosporidium 
Globally, only a few studies to date have been conducted to screen Cryptosporidium from 
swimming pool filter backwash that are not implicated in outbreaks. The present study reports 
for the first time, the feasibility of using filter backwash as a screening medium for 
Cryptosporidium in four swimming pools and two splash parks in WA. Infected individuals 
can act as source of Cryptosporidium contamination of swimming pools via faecal material 
(Gerba, 2000) and as oocysts can survive in swimming pool water for up to 10 days when 
normal chlorine levels are maintained. Therefore,  a testing method that involves direct and 
reliable detection of Cryptosporidium from filter backwash would assist early surveillance of 
swimming pools and potentially avoid outbreaks. 
Unfortunately, Cryptosporidium spp. were not detected in any of the filter backwash 
samples collected in the present study. The absence of Cryptosporidium may indicate that the 
parasite was not present  in the pool systems analysed or that levels were too low for detection. 
Importantly, the methodology for collecting the filter backwash had significant limitations and 
further optimisation is required. Filter backwash screening to detect Cryptosporidium is crucial 
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to provide a more direct measure of human risk and development of earlier surveillance to 
control cryptosporidiosis at the source.  
 Knowledge, attitude and practices of swimming pool patrons and staff associated 
with cryptosporidiosis outbreaks 
Identifying and understanding the KAP of both swimming pool patrons and staff is 
critical for the control and prevention of Cryptosporidium outbreaks in the community. While 
evidence has shown that adherence to disease control measures are substantially reduced if 
community KAP levels are low (Tachfouti et al., 2012; Ajilore et al., 2017; Reuben et al., 
2020), studies to assess the KAP of patrons and staff are limited, and to the best of our 
knowledge, there are no reports of intervention studies based on Cryptosporidium and KAP 
findings. In addition to improving the education level of patrons and staff to prevent the 
introduction of oocysts into swimming pools, specific recommendations limiting the spread of 
cryptosporidiosis include a need for uniform national and international standards governing 
cryptosporidiosis outbreaks (Ryan et al., 2017a). For instance, following an outbreak in NSW, 
a PHU advised parents of children with diarrhoea to refrain from swimming for at least one 
week following cessation of diarrhoeal symptoms (Black and McAnulty, 2006), which is 
contrary to the two weeks recommended by the Department of Health, WA (WA Department 
of Health, 2019). 
The data generated in the present study provided fundamental information that is 
applicable for developing public health programs to manage Cryptosporidium infections 
through interventions encompassing personal hygiene and health education. In NSW, many 
children’s learn-to-swim centres have now introduced catch-up lessons for children who had 
diarrhoea and parents of children are asked to sign a declaration confirming that their child has 
not had diarrhoea in the past week prior to their swim class (NSW Health, 2013). Another 
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promising approach is to provide better education to the public by integrating Cryptosporidium 
awareness into the school curriculum from a young age. Furthermore, raising the awareness 
and hygiene-related practices through the delivery of targeted health education messages to the 
general public is essential to reduce the burden of Cryptosporidium infections in aquatic 
environments. 
 Limitations of the current project 
A limitation of this thesis was the relatively small number of Cryptosporidium-positive 
samples that were available for subtyping. Cryptosporidium-positive faecal samples in Chapter 
2 were all obtained from one local clinical pathology laboratory in WA that were initially 
detected only by microscopy, which lacks sensitivity and cannot identify Cryptosporidium to 
species level. Cryptosporidium-positive faecal samples for Chapter 4 were obtained from an 
additional two pathology laboratories that initially screened faecal samples by qPCR. Future 
studies in WA require routine molecular identification and subtyping of all notified 
Cryptosporidium cases to supplement epidemiological investigations of Cryptosporidium. 
Another limitation was that epidemiological investigations via phone interview by the 
Department of Health staff were not conducted on all outbreak cases and therefore in many 
cases, it was not possible to match up with available subtype data. It was also difficult to 
determine the travel history of many of the cases implicated in the outbreaks, notably whether 
the emergent subtypes were acquired locally or originated from overseas. Also due to the time 
lapse between the initial faecal sample collection and the recognition that an outbreak was 
occurring, it was not possible to go back to implicated pools at the time and sample the water 
and filter backwash for Cryptosporidium. 
Another major limitation of the present study was the unwillingness of public swimming 
pools and splash park managers to participate in both the KAP and filter backwash studies, as 
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initial direct contact with all aquatic venues were unsuccessful. This was partially overcome 
by engaging with Department of Health staff to directly contact the City Councils operating 
the pools, leading to the participation of several pools. Screening of a larger number of 
swimming pool water samples would provide a more robust evidence to supplement the 
epidemiological investigations and link the Cryptosporidium outbreak subtypes in the human 
cases with respective swimming pools. In doing so, closure or superchlorination of implicated 
swimming pools could have been enforced earlier to prevent additional infections. 
Furthermore, routine filter backwash investigations can provide a more robust evidence base 
for the role pools play in Cryptosporidium transmission and the subsequent advice and 
guidelines provided by Health Departments and regulators. For a more extensive representation 
of the KAP of patrons and staff around swimming pools, future studies should be expanded to 
a larger number of aquatic facilities. 
 Future research 
Studies reported in this thesis have increased our understanding of the transmission 
dynamics of Cryptosporidium and the KAP of swimming pool patrons and staff in WA. Large 
scale surveillance studies however, using molecular tools, particularly NGS, in sporadic and 
outbreak infections are needed to assess the genetic diversity of Cryptosporidium associated 
with infections in WA and around Australia. Utilising NGS will help to better understand the 
full diversity of Cryptosporidium that is responsible for causing diarrhoeal disease, the extent 
of co-infections and the transmission dynamics within the infected population. WGS analysis 
of a subset of these samples will be important for providing a more complete picture of 
transmission dynamics as well as understanding vaccine coverage requirements when 
developing vaccines and for the development of therapies to control Cryptosporidium 
infections. 
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Studies on the transmission of Cryptosporidium have until recently been hampered by 
the lack of suitable subtyping tools. Whole genome sequencing is increasingly being used to 
extend the range of variable loci to provide high-resolution subtyping of Cryptosporidium in 
both humans and animals and to better understand the geographic substructure within isolates. 
Further molecular epidemiological studies are required to understand the epidemiology of 
zoonotic and wildlife-adapted species, particularly in areas that are in close proximity to water 
catchments. 
Studies to analyse water treatment systems, chemical-physical parameters, volume of 
pool and bather loading, turnover rates, filtration type, patron type, and UV for the control and 
management of Cryptosporidium risks should be conducted. Lastly, an important knowledge 
gap is the role of education on the KAP of patrons and staff around swimming pools. This 
should be addressed in future studies employing targeted educational interventions for both 
swimming pool patrons and staff. 
 Recommendations 
Despite Cryptosporidium being a notifiable disease in WA, significant research gaps still 
remain in understanding the transmission dynamics of cryptosporidiosis of swimming pool 
origin. 
• Clinical pathology laboratories in WA should be equipped with Cryptosporidium 
genotyping capabilities to implement typing as part of their routine investigations. This 
would allow surveillance to include  species and subtype data into the existing 
WANIDD database and enable epidemiological interpretation of Cryptosporidium 
genotype occurrence and distribution trends in both sporadic and outbreak cases.  
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• Ongoing molecular surveillance of Cryptosporidium is recommended to provide a 
better understanding of swimming pool-associated cryptosporidiosis infections 
including travel-associated infections. 
• Routine filter backwash screening is recommended to identify sources of outbreaks and 
to enable proactive sampling to identify risks following an AFR, i.e. to show 
clearance/absence of oocysts post AFRs. Pariticipation of additional swimming pools 
including physical-chemical measurements (pool volume, levels of chlorine, pH, 
temperature and number of days since previous filter backwash)  should be included in 
future studies to provide a clearer understanding of factors contributing to the 
transmission dynamics of Cryptosporidium in swimming pools. 
• The Department of Health, WA should enhance health education campaigns to raise 
awareness about Cryptosporidium risk factors around swimming pools in order to adopt 
better healthy behaviours and to support targeted interventions to prevent further 
outbreaks. Campaigns around swimming pools to raise awareness of Cryptosporidium 
transmission, infections and sources are essential to improve unhealthy behaviours 
among swimming pool patrons and staff. Communicating best practice behaviour to 
patrons and staff via banners, brochures and signage is recommended. Also, including 
additional languages in brochures will help to inform members of the general public for 
whom English is not their first language. 
 Conclusions 
In conclusion, this thesis has demonstrated the evolving nature of cryptosporidiosis 
subtypes in the WA population and the utility of molecular typing in tracking both community 
and swimming pool-associated outbreaks. Although, C. hominis dominates, the zoonotic risk 
of Cryptosporidium spp. in WA reported in the present thesis should be investigated further. 
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Routine typing of cases and filter backwash investigations would be valuable to provide data 
on the epidemiology of Cryptosporidium in WA. The KAP data generated in this thesis 
prompts for further investigations to increase the knowledge of Cryptosporidium among 
swimming pool patrons and staff to improve unhealthy swimming behaviours and reduce 
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A  B  S  T  R  A  C T 
 
Cryptosporidium species are a major cause of diarrhoea worldwide. In the present study, a retrospective analysis of 109 
microscopically Cryptosporidium-positive faecal specimens from Western Australian patients, collected between 2015 and 
2018 was conducted. Sequence analysis of the 18S rRNA and the 60 kDa glycoprotein (gp60) gene loci identified four 
Cryptosporidium species: C. hominis (86.2%, 94/109), C. parvum (11.0%, 12/109), C. meleagridis (1.8%, 2/109) and C. 
viatorum (0.9%, 1/109). Subtyping at the gp60 locus identified a total of 11 subtypes including the emergence of the previously 
rare C. hominis IfA12G1R5 subtype in 2017 as the dominant subtype (46.7%, 21/45). This subtype has also recently emerged 
as the dominant subtype in the United States but the reasons for its emergence are unknown. This is also the first report 







Cryptosporidium species are enteric protozoa that are a major cause of 
moderate-to-severe diarrhoea in children younger than two years of age 
in South Asia and sub-Saharan Africa, and are a major risk factor for 
stunting and poor growth (Kotloff et al., 2013; Sow et al., 2016). Cur- 
rently, 38 Cryptosporidium species are recognised with C. parvum and C. 
hominis accounting for most infections in humans (Feng et al., 2018). 
Oocysts of most Cryptosporidium spp. are morphologically similar 
and therefore genotyping and subtyping tools are essential to char- 
acterize Cryptosporidium epidemiology and transmission dynamics. 
Studies worldwide have shown that C. hominis is the most dominant 
Cryptosporidium species infecting humans in most countries (Xiao, 
2010). Although C. hominis is largely human specific, it has also been 
identified in domestic animals and wildlife hosts including sheep, goats, 
cattle, a dugong, non-human primates and kangaroos (Xiao, 2010; 
Zahedi et al., 2016, 2018). 
Several Cryptosporidium species have been reported in Australians 
including C. hominis, C. parvum, C. meleagridis, C. fayeri, C. andersoni, 
C. bovis, C. cuniculus, C. felis, a novel Cryptosporidium species most closely 
related to C. wrairi and the Cryptosporidium mink genotype (Koehler et 
al., 2014; Ebner et al., 2015; Ng-Hublin et al., 2017, 2018). Sequence 
analysis of the 60-kDa glycoprotein (gp60) gene is one of the most 
commonly used subtyping tools for studying the transmission dynamics of 
Cryptosporidium. Over 10 subtype families (Ia, Ib, Id, Ie, If, Ig, Ih, Ii, Ij and 
Ik) have been identified in C. hominis with subtype IbA10G2 re- sponsible 
for the majority of C. hominis-associated outbreaks of cryp- tosporidiosis 
worldwide (Chalmers et al., 2010; Xiao, 2010; Widerstrom et al., 2014; 
Roelfsema et al., 2016; Feng et al., 2018). 
Previous studies of cryptosporidiosis among human populations in 
Western Australia (WA) (Ng et al., 2010a, 2010b; Ng-Hublin et al., 2015, 
2017) and other areas of Australia (Jex et al., 2007, 2008; Mayne et al., 
2011; Waldron et al., 2011a, 2011b; Koehler et al., 2014), have shown that 
subtype IbA10G2 is the most dominant subtype responsible for both C. 
hominis-associated outbreaks and sporadic cases of cryp- tosporidiosis in 
Australia, while C. hominis subtype IdA15G1 is the dominant subtype 
infecting Aboriginal populations in Western Aus- tralia (Ng-Hublin et al., 
2017). In addition to C. hominis subtypes, a range of C. parvum 
(IIaA15G2R1, IIaA17G2R1, IIaA18G3R1, IIaA19G3R1, IIaA19G4R1, 
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IIaA23G3R1,  IIcA5G3a,  IIcA5G3R2,  IIdA15G1,  IIdA18G2,  IIdA19G2, 
IIdA22G2R1,   IIdA23G1,   IIdA24G1   and   IIeA17G1),   C.   
meleagridis 
(IIIeA18G2R2), C. fayeri (IVaA9G4T1R1, IVaA10G3T1R1) and C. 
cuni- 
culus (similar to VbA25) subtypes have also been reported in Aus- 
tralians (Jex et al., 2007; O'Brien et al., 2008; Ng et al., 2010a, 2010b; 
Pangasa et al., 2010; Waldron et al., 2010, 2011a, 2011b; Ng et al., 2012; 
Ng-Hublin et al., 2013a; Koehler et al., 2014; Ng-Hublin et al., 2017, 
2018). 
In the present study, we conducted a retrospective analysis of sporadic 
cryptosporidiosis cases reported in WA between 2015 and 2018 and 
examined the Cryptosporidium species and subtypes in Western 
Australian humans. The study revealed an extensive genetic diversity (11 
Cryptosporidium subtypes belonging to four species in 109 human faecal 
samples), and report the emergence of a previously rare 
C. hominis subtype, IfA12G1R5, as the dominant subtype in 2017. C. 
viatorum was also reported for the first time in Australia and was 
identified as a novel C. viatorum subtype. 
 
2. Materials and methods 
 
2.1. Stool collection and processing 
 
A total of 109 sporadic Cryptosporidium-positive human faecal samples 
were collected from a pathology centre in WA from 2015 to 2018 (Table 
1), of which the presence of Cryptosporidium oocysts in each faecal 
sample was initially confirmed by microscopy. Briefly, fixed faecal smears 
were stained with heated Safranin (1% aqueous stain) and 
counterstained with Methylene-blue (1% aqueous stain) as pre- viously 
described (Baxby et al., 1984). Cryptosporidium oocysts were 
then examined under oil immersion at x100 objective and were iden- tified 
as bright orange-red, usually with a clear halo and ~5 μm in size. Positive 
samples were transported to Murdoch University in 75 ml 
faecal collection containers on ice and stored at 4 °C prior to DNA ex- 
traction and molecular analysis. 
 
2.2. DNA isolation 
 
Whole genomic DNA was extracted from each Cryptosporidium-po- 
sitive faecal specimens using a MOBIO Power Soil DNA Isolation Kit 
(MOBIO, Carlsbad, California) following the manufacturer's instruc- tions 
with modifications as described by Ng-Hublin et al. (2013b). Ex- traction 
reagent blanks (no faecal sample) were used in each extraction group. The 





Distribution of Cryptosporidium species and gp60 subtypes identified in Western 
Australian humans from 2015 to 2018. 
 
Species Subtypes Year (No. positive) Subtype total n (%) 
 
 
2015 2016 2017 2018 
 
C. hominis IbA10G2 0 21 7 0 28 (25.7) 
 IdA15G1 20 3 12 2 37 (33.9) 
 IdA19 0 0 1 0 1 (0.9) 
 IfA12G1R5 1 6 21 0 28 (25.7) 
C. parvum IIaA17G2R1 1 0 0 0 1 (0.9) 
 IIaA18G3R1 0 2 1 2 5 (4.6) 
 IIaA19G4R1 0 3 0 0 3 (2.8) 
 IIcA5G3a 0 2 1 0 3 (2.8) 
C. meleagridis IIIbA23G1R1c 0 0 1 0 1 (0.9) 
 IIIeA18G2R1 0 0 1 0 1 (0.9) 
C. viatorum XVaA3g 0 0 0 1 1 (0.9) 
Total  22 37 45 5 109 (100) 
2.3. PCR amplification at 18S rRNA and gp60 gene 
 
Initial characterisation of Cryptosporidium species in faecal samples (n 
= 109) was carried out by nested PCR amplification and Sanger se- 
quencing of an ~830 bp fragment of the Cryptosporidium 18S rRNA gene 
as described by Xiao et al. (2001). Samples that were characterised as C. 
hominis and C. parvum at the 18S locus, were then subtyped at gp60 locus 
using a nested PCR to amplify an ~830 bp product as previously described 
(Strong et al., 2000; Sulaiman et al., 2005). C. meleagridis and 
C. viatorum gp60 subtyping was also conducted as previously described 
(Stensvold et al., 2014, 2015). 
 
2.4. Sanger sequencing and  phylogenetic  analysis 
 
Amplified DNA fragments were separated by agarose gel electro- 
phoresis, purified for sequencing at both loci using an in-house filter tip 
method as previously described (Yang et al., 2013), and sequenced in 
both directions using an ABI Prism™ Dye Terminator Cycle Sequencing kit 
(Applied Biosystems, Foster City, California) according to the 
manufacturer's instructions, with annealing temperature of 57 °C for 18S 
rRNA as described by Zahedi et al. (2018); and 58 °C for both C. 
meleagridis (Stensvold et al., 2014) and C. viatorum (Stensvold et al., 
2015). Sanger sequencing chromatogram files were imported into 
Geneious Pro 8.1.6 (Kearse et al., 2012), and the nucleotide sequences 
were analyzed and aligned with reference sequences from GenBank 
using Clustal W (http://www.clustalw.genome.jp). 
 
2.5. Demographic data and data analysis 
 
Laboratory identification numbers of the 109 faecal samples pro- 
vided by the testing lab were cross-referenced with the Western 
Australian Notifiable Infectious Disease Database (WANIDD) to de- 
termine the age, gender, and public health unit (PHU) and were con- 
firmed to be distinct (not replicates). Public Health Units (PHU) in 
Western Australia are divided into 3 regions: Remote (Kimberly, 
Pilbara, Goldfields), Rural (Midwest, Wheatbelt, Southwest) and 
Metropolitan (North Metropolitan, South Metropolitan, East 
Metropolitan). A case that is not a resident of WA is denoted by NOWA. 
The population in the present study was then compared to the 
overall cryptosporidiosis notification data obtained from the Western 
Australian Notifiable Infectious Disease Database (WANIDD) from 2015 
to 2018. Data analysis was conducted using Microsoft Excel® 2016 and 




3.1. Overall prevalence of Cryptosporidium species and subtypes detected in 
faecal samples 
 
All 109 microscopically Cryptosporidium positive samples from the 
pathology laboratory collected between 2015 and 2018, were success- 
fully amplified and sequenced at both the 18S and gp60 loci and con- firmed 
as Cryptosporidium-positive using molecular tools. Sequence typing at the 
18S rRNA of the 109 cryptosporidiosis notifications identified four 
Cryptosporidium species; the majority of specimens identified were C. 
hominis (94/109), followed by C. parvum (12/109), C. meleagridis (2/109) 
and a single case of a novel C. viatorum variant (1/ 109) (Table 1, Fig. 1). 
Sequence analysis of the gp60 locus successfully identified 11 
Cryptosporidium subtypes within the four Cryptosporidium species iden- 
tified (Fig. 1; Table 1). The most common subtype, C. hominis IdA15G1, was 
identified in 37/109 (33.9%) isolates. The next most abundant detected 
subtypes were C. hominis IbA10G2 and IfA12G1R5, which were 
identified in 28/109 (25.7%) isolates respectively (Table 1). The novel C. 
viatorum positive sample was subtyped as XVaA3g. Nucleotide 
sequences reported in the present study including the novel C. viatorum
    





































Fig. 1. Cryptosporidium species and gp60 subtypes identified from reported cases of Cryptosporidiosis A. Overall Cryptosporidium species between (2015–2018), and B. Percentage 
(%) of the three most commonly reported Cryptosporidium hominis subtypes (IfA12G1R5, IdA15G1 and IbA10G2) identified in WA humans from 2015 to 2017. 
 
XVaA3g variant have been deposited in the GenBank database under the 
accession numbers: MK165981-MK165987 and MK165989- MK165992. 
 
3.2. Demographic data 
 
Demographic data were obtained for all 109 individuals (Fig. 1; Fig. 
2; Fig. 3). Males accounted for 41.3% (45/109) of the reported cases 
whereas 58.7% (64/109) were female (Fig. 2A). The highest number of 
cases occurred in the 0–4 years age group, comprised 45.0% (49/109) of 
reported cases, and of these, 23.9% (26/109) were male and 21.1% 
(23/109) were female. A second peak was observed in the 20–24 to 35–39 
age groups, which were predominantly female, i.e. 25.7% (28/109) (Fig. 
2A). Compared to the total Cryptosporidium no- tifications in WA, our study 
population did resemble closely the state- wide age-group trend (high 
notifications in the 0–4 age-group and the higher proportion of infected 
females between the 20–24 to 35–39 age groups) (Fig. 2A; Fig. 2B). Despite 
the similar trends in some of the age- groups however, it is not possible to 
infer that the samples genotyped in the present study are representative 
of the total notifications reported in WA. 
Out of the present study population, the largest number of reports 
were obtained from the Kimberley 25.7% (28/109) and Pilbara 23.9% 
(26/109) regions, followed by the Southwest 10.1% (11/109), East 
Metropolitan 9.2% (10/109), Midwest 8.3% (9/109), North 
Metropolitan 7.3% (8/109), South Metropolitan 6.4% (7/109), 
Goldfields and Wheatbelt both at 3.7% (4/109) and non-WA residents 
with a total of 1.8% (2/109) cases (Table 2, Fig. 3). C. hominis subtype 
IdA15G1 was identified predominantly in remote  areas  (31.2%, n=  
34), with only 1.8% (n = 3) reported from rural and metropolitan areas 
combined (Table 2). C. hominis subtype IbA10G2 was identified in remote 
(11.9%,  n= 13),  rural  (3.7%,  n=  4),  metropolitan  (9.2%, n = 10) 
areas and in a single non-WA resident (0.9%, n=  1). Subtype IfA12G1R5 
was identified across remote (6.4%, n= 7), rural (11.0%, n = 12) and 
metropolitan areas (8.3%, n=  9) (Table 2). Due to the small number of 
cases from each Public Health Units (PHU), no sta- tistically significant 
association could be made. The samples identified in the present study are 





The present retrospective study has identified that consistent with 
previous analyses (Ng et al., 2010b; Ng-Hublin et al., 2017, 2018), C. 










































































Fig. 2. Distribution of Cryptosporidium species in WA by age and gender between 2015 and 2018. A. genotyped samples reported in this study B. Total Cryptosporidium 
notifications in Western Australia (n = 1022). 
 
hominis is the dominant Cryptosporidium species infecting humans in WA 
and was responsible for 86.2% of all infections. Cryptosporidium 
prevalence peaked in the 0–4 age group with a second spike in the 21–
30 and 31–40. A similar bimodal age pattern was seen in non- Aboriginal 
populations in a previous study in WA by Ng-Hublin et al. (2017), which 
was in contrast to a unimodal distribution of notifica- tions for age groups 
in Aboriginal people, with 93.2% of cases reported in the 0–4 years age 
group (Ng-Hublin et al., 2017). In the present study, the ethnicity of all 
individuals could not be determined and therefore comparisons between 
Aboriginal and non-Aboriginal popu- lations cannot be made. A bimodal 
age-related pattern of cryptospor- idiosis is common in industrialised 
nations with the second peak at- tributed to transmission from infected 
children to predominantly female caregivers, through faecal-oral 
contamination during nappy changing for example (Robertson et al., 
2002; Hunter et al., 2004; Yoder et al., 2012; Painter et al., 2015). 
The   most   prevalent   C.   hominis   subtype   in   the   present   study 
(IdA15G1) was previously reported as the dominant subtype infecting 
Aboriginal people in WA (Ng-Hublin et al., 2017), whereas data from 
2002 to 2017 indicated that IbA10G2 mainly infected non-Aboriginal 
people from urban areas (Ng et al., 2010b; Ng-Hublin et al., 2017, 
2018). In the present study, IdA15G1 was also the dominant subtype in 
remote  Public  Health  Units,  which  have  a  higher  proportion  of 
Aboriginal people compared to other PHUs. Subtype IbA10G2 was 
dominant in both remote and metropolitan areas, whereas IfA12G1R5 was 
common across remote, rural and metropolitan areas. However, in the 
present study, as the Aboriginal status is unknown, correlations between 
the prevalence of subtype in Aboriginal versus non-Aboriginal populations 
cannot be made. 
Sequence analysis of the gp60 locus successfully identified 11 
Cryptosporidium subtypes, including the emergence of the IfA12G1R5 
subtype in 2017 as the dominant subtype reported in WA, where it 
accounted for 46.7% of all typed cryptosporidiosis cases in that year. 
Until recently, IfA12G1R5 was a relatively rare subtype, that has pre- 
viously only been identified in a few sporadic cryptosporidiosis cases in 
WA (Ng et al., 2010a) and the United Kingdom (Chalmers et al., 2008). 
In 2009, it was first reported in the United States in individuals with 
acquired immunodeficiency syndrome (AIDS) and was also responsible for 
an outbreak of cryptosporidiosis in Oregon, USA, associated with the 
care of an AIDS patient (Hlavsa et al., 2017). In 2013, it emerged as the 
dominant C. hominis subtype among sporadic and outbreak asso- ciated 
cases in the USA (for which Cryptosporidium subtyping data was available) 
(Hlavsa et al., 2017) and in 2016, was responsible for 36.6% (107/292) of 
sporadic cryptosporidiosis cases and was also associated with swimming 
pool cryptosporidiosis outbreaks in Alabama and Ar- izona (Hlavsa et al., 






































Fig. 3. Distribution of Cryptosporidium notifications per Public Health Unit (PHU) in WA A. notifications from this study and B. overall notifications reported in WA. 
C. Map of Western Australia public health unit (PHU) classification of health administrative regions - urban Perth is divided into North, South and East Metropolitan regions, 
Map weblink: http://www.wacountry.health.wa.gov.au/fileadmin/sections/publications/Publications_by_topic_type/Maps/WACHS_M_Regions.pdf 
 
subtype in 2017 in WA and in the USA is not well understood but may have 
come from recombination between related subtypes, as has been the case 
for the emergence of the hyper-transmissible C. parvum IIaA15G2R1 
subtype and C. hominis subtype IaA28R4 (Feng et al., 2013, 2014, 2018). 
In the present study, C. hominis subtype IdA19 is only reported once, 
in 2017. This subtype was initially identified in a sporadic case in northern 
Ontario, Canada (Trotz-Williams et al., 2006), and is a rare C. hominis 
subtype infecting humans (Ong et al., 2008). It has been asso- ciated with 
a waterborne outbreak in North Battleford, Saskatchewan, Canada (Ong 
and Isaac-Renton, 2003; Ong et al., 2005), and recently has been 
reported worldwide in a number of countries including China (Feng et al., 
2012; Wang et al., 2013), Kenya (Mbae et al., 2015), Co- lombia (Sanchez 
et al., 2017), and as the predominant subtype in symptomatic patients in 
Lebanon (Osman et al., 2015). Despite being a relatively rare C. hominis 
subtype, IdA19 was recently implicated in a massive waterpark-associated 
outbreak in Ohio, USA (Hlavsa et al., 2017). 
Our results also showed that after C. hominis, C. parvum was the 
second most common species in sporadic cases. The C. parvum subtypes 
identified in the present study include three zoonotic IIa subtypes 
(IIaA17G2R1, IIaA18G3R1 and IIaA19G4R1) and the largely anthro- 
ponotically-transmitted IIc subtype family (IIcA5G3a). The IIa subtype 
family has been previously reported in numerous studies in developed 
countries   (USA,   Canada,   Northern   Ireland,   Germany,   Spain,   The 
Netherlands, Italy and Australia) in both humans and animals, in par- 
ticular calves (Xiao, 2010). An outbreak investigation by the Centers for 
Disease Control and Prevention (CDC) at a camp in North Carolina, USA, 
reported subtype IIaA17G2R1 in more than half of the outbreak infections, 
and the same subtype was identified in the animal faeces around the camp, 
further highlighting the zoonotic potential of this subtype (CDC, 2011). 
C. parvum subtype IIaA18G3R1 is a common subtype in calves and 
humans in Ireland, Australia, and New Zealand (Thompson et al., 2007; 
Ng et al., 2008; Waldron et al., 2009; Zintl et al., 2009; Al Mawly et al., 
2015). Similarly, subtype IIaA19G4R1 identified in the present study 
have previously been reported in Australia in both Aboriginal and non- 
Aboriginal Western Australians (Ng-Hublin et al., 2017). 
WANIDD confirmation of isolates identified the largely anthro- 
ponotically-transmitted C. parvum IIcA5G3a in three isolates and fur- ther 
analysis showed that all three patients had no history of interna- tional 
travel and were acquired locally. This finding may further support the 
anthroponotic transmission of this subtype in WA as the IIc subtype is 
considered predominantly anthroponotic in origin (Xiao and Ryan, 2004) 
and was previously reported only in humans (Alves et al., 2003; Peng et al., 
2003; Xiao et al., 2004). More recently, subtype II- cA5G3j was detected in 
hedgehogs (Erinaceus europaeus) in Germany and the UK (Dyachenko et 
al., 2010; Sangster et al., 2016) and II- cA5G3q was identified in a goat 
in Ghana (Squire et al., 2017). 
Two C. meleagridis subtypes (IIIbA23G1R1c and IIIeA18G2R1) were 





identified, and although predominantly a bird parasite, C. meleagridis is 
commonly reported in humans and is the third most common 
Cryptosporidium species causing disease in humans in Australia (Ng- 
Hublin et al., 2017). Studies on the anthroponotic versus zoonotic 
transmission of C. meleagridis are lacking but a study in Hubei Province, 
China, reported the same C. meleagridis subtype (IIIbA23G1R1c) in 
chickens and humans (Liao et al. (2018) and subtype IIIeA18G2R1 has 
been identified in animals inhabiting drinking water catchments in 
Australia (Zahedi et al., 2018). 
This is the first report of C. viatorum from a human in WA and also 
the first report in Australia. A novel subtype, XVaA3g was identified which 
clustered within all other human C. viatorum sequences. C. via- torum was 
first described in 2012 from travellers returning to the United Kingdom 
from the Indian subcontinent (Elwin et al., 2012) and has since been 
reported globally. It was initially thought to occur ex- clusively in 
humans, but subtype XVbA2G1 has recently been identified in the native 
Australian swamp rat (Rattus lutreolus), suggesting that rodents may be a 




Our study highlights the occurrence and emergence of Cryptosporidium 
subtypes that could potentially cause future disease outbreaks. Despite the 
dominance of the C. hominis IbA10G2 subtype in non-Aboriginal humans 
in WA from as early as 2002 until 2017, for the first time we report the 
emergence of the previously rare C. hominis subtype IfA12G1R5 as the 
dominant subtype in 2017. We also report for the first time, the 
identification of C. viatorum in Australia and the characterisation of a novel 
C. viatorum subtype. Knowledge of me- chanisms behind the emergence of 
virulent C. hominis subtypes such as the IfA12G1R5 and other successful 
subtypes infecting humans is cri- tical to improved understanding of 
cryptosporidiosis epidemiology. Whole Genome Sequencing (WGS) of 
these novel emerging subtypes is essential to provide us with new tools in 
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1  | INTRODUCTION 
Continued human encroachment into wildlife-populated   areas and 
the expansion of wildlife into urban areas increases the risk of spill 
over and spill back of zoonotic pathogens. Cryptosporidium is an 
important protozoan parasite that infects a wide range of hosts and 
is transmitted primarily by faecal-oral contamination. Cryptosporidial 
infections in humans and animals can range from asymptomatic to 
severe diarrhoea and can cause prolonged and sometimes fatal 
infections in immunocompromised humans (Gerace et al., 2019). 
The parasite is a major cause of diarrhoeal illness and mortal- ity in 
young children (GBD, 2017) and the only US Food and Drug 
Administration (FDA) approved drug, nitazoxanide, has poor efficacy in 
immunocompromised individuals (Amadi et al., 2009). Currently, 42 
Cryptosporidium species are recognised with C. hominis and C. 
parvum the main species infecting humans (Zahedi & Ryan, 2020). 
Many species were originally thought to be host specific; however 
this is increasingly being questioned (Widmer et al., 2020; Zahedi et 
al., 2016). 
On 1 March 2020, a 37-year-old immunosuppressed female treated for 
acute myeloid leukaemia in Western Australia (WA) was admitted to 
hospital with a 3-day history of nausea, vomiting, ab- dominal pain and 
diarrhoea as well as a worsening maculopapular rash over her neck and 
torso. The patient was diagnosed with cryp- tosporidiosis when oocysts 
were detected in a faecal sample by mi- croscopy. The patient had no 
known recent travel history or contact with ill acquaintances or wildlife. 
 
 
2  | METHODS  
 
On 3 March 2020, routine stool microscopy at a local pathol- ogy 
laboratory was positive for Cryptosporidium species. On 15 March 
2020, DNA was extracted from the sample using a Qiagen DNeasy 
tissue kit (Qiagen, Hilden, Germany) and Cryptosporidiu
Abstract 
In the present study, a 37-year-old immunosuppressed female in Western Australia (WA) was 
identified as positive for Cryptosporidium by microscopy and treated with nitazoxanide. 
Molecular analyses at the 18S ribosomal RNA (18S) and 60 kDa glyco- protein (gp60) loci 
identified C. fayeri subtype IVgA10G1T1R1, which had previously been identified in western 
grey kangaroos (Macropus fuliginosus) in WA. Next genera- tion sequencing (NGS) of the gp60 
locus confirmed the absence of mixed infections with other Cryptosporidium species. This is 
only the second report of C. fayeri in a human host highlighting the zoonotic potential of this 
wildlife-associated species. Routine diagnosis using molecular methods in laboratories is 
required to better un- derstand the diversity and epidemiology of Cryptosporidium parasite. 
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2 |   
 
was amplified and sequenced at the 18S rRNA (18S) locus (Xiao et 
al., 2001) resulting in the identification of C. fayeri. As a conse- quence, 
C. fayeri specific primers targeting the gp60 locus (Power et al., 2009) 
were then used to subtype the sample. Amplicon next generation 
sequencing (NGS) using gp60 primers was also con- ducted on the 
sample to determine the presence of mixed C. par- vum, C. hominis and 
C. cuniculus infections as previously described (Zahedi et al., 2017). 
This study has prior approval from the Murdoch University Human 
Research Ethics approval number: 2017/239, and WA Department of 
Health HREC number: 2018/23. 
 
 
3  | RESULTS 
 
Subtyping at the gp60 locus identified C. fayeri subtype IVgA10G1T1R1, 
confirming the identification of C. fayeri at the 18S locus. The 18S and 
gp60 nucleotide sequences of the C. fayeri identified in the present 
study were deposited in GenBank under the accession numbers 
MT928783, and MT952954, respectively. Amplicon next generation 
sequencing failed to match 100% pair- wise identity and query cover 
with reference sequences, indicating no mixed C. parvum, C. hominis 
and C. cuniculus infections within the 
C. fayeri isolate. 
Following the initial detection of Cryptosporidium oocysts in the patient 
stool sample on March 3rd, the patient was put on a 3-day course of 
nitazoxanide. On the 11th of March 2020, Cryptosporidium was not 
detected on limited microscopic examination, however a full parasite 
examination was not requested. In addition, diarrhoeal symptoms were 
still ongoing when the patient was discharged into palliative care. 
 
 
4  | DISCUSSION 
 
The present study is only the second report of C. fayeri infection in a 
human host. In the previous study, a 29-year-old immunocompetent 
woman in New South Wales (NSW), Australia, sought care because of 
prolonged gastrointestinal illness (Waldron et al., 2010). In that study, 
the patient was diagnosed as positive for Cryptosporidium using an 
enzyme immunoassay (EIA) and C. fayeri subtype IVaA9G4T1R1 was 
identified upon molecular screening (Waldron et al., 2010). The same 
C. fayeri subtype had previously been identified from eastern grey 
kangaroos (Macropus giganteus) inhabiting the main drinking water 
catchment for Sydney (Power et al., 2009). The patient resided in a 
national forest in NSW and had frequent contact with marsupi- als, 
suggesting zoonotic transmission (Waldron et al., 2010). 
In the present study, the C. fayeri subtype IVgA10G1T1R1 iden- tified 
in the immunosuppressed female patient, had previously been reported 
in western grey kangaroos (Macropus fuliginosus) and rab- bits 
(Oryctolagus cuniculus) in drinking water catchments in WA and NSW, 
respectively (Zahedi et al., 2018). Marsupials are the domi- nant animals 
inhabiting drinking water catchments in Australia, with 
the majority infected with C. fayeri and/or C. macropodum (Koehler  et 
al., 2016; Nolan et al., 2013; Zahedi et al., 2018). In addition to 
apparently host-specific genotypes such as brushtail possum geno- type 
I (Hill et al., 2008), kangaroo genotype I (Yang et al., 2011) and 
Tasmanian devil genotype I (Wait et al., 2017), a range of additional 
species, many of which are zoonotic have been identified in mar- supials 
including C. hominis, C. parvum, C. muris (Dowle et al., 2013; Hill et al., 
2008; Ng et al., 2011; Warren et al., 2003), C. xiaoi (Yang et al., 2011), 
C. ubiquitum and C. meleagridis (Vermeulen et al., 2015), 
C. cuniculus (Koehler et al., 2014), C. galli (Wait et al., 2017) and C. 
erinacei (Zahedi et al., 2018). 
The absence of other Crypotsporidium species using NGS sug- gests 
infection by a single C. fayeri subtype. Identification of C. fayeri clinical 
infection in a human patient is a public health concern, as until recently 
this species was thought to be host-adapted, but has now been reported 
in two human patients, one of which was immu- nocompetent. The 
source of the C. fayeri infection in the immuno- suppressed patient in 
the present study is unknown, but potential sources include 
contaminated water. Nitazoxanide has previously been reported to be 
ineffective in immunocompromised individuals (Amadi et al., 2009) and 
in the present study the clinical symptoms were not resolved in the 
patient. Clearly further studies are required to determine the zoonotic 
potential and transmission dynamics of C. fayeri and of wildlife-
associated Cryptosporidium in general. 
 
 
5  | CONCLUSIONS 
 
In addition to the current use of microscopy, routine molecular typ- ing 
in diagnostic laboratories to better understand the transmission 
dynamics of Cryptosporidium species in humans, needs to be con- 
ducted. This study reinforces the need to consider cryptosporidiosis as 
a cause of gastrointestinal disease in immunocompromised peo- ple. It 
also highlights the need for enhanced infection control meas- ures for 
at least 14 days after symptoms cease to avoid secondary transmission. 
This is especially important given the patient contin- ued to be 
symptomatic for an extended period of time 
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A B S T R A C T   
 
Cryptosporidium is an important protozoan parasite and due to its resistance to chlorine is a major cause of  swimming 
pool-associated gastroenteritis outbreaks. The present study combined contact tracing and molecular  techniques to 
analyse cryptosporidiosis cases and outbreaks in Western Australia in 2019 and 2020. In the 2019  outbreak, 
subtyping at the 60 kDa glycoprotein (gp60) gene identified 89.0% (16/18) of samples were caused by the C. hominis 
IdA15G1 subtype. Amplicon next generation sequencing (NGS) at the gp60 locus identified five 
C. hominis IdA15G1 subtype samples that also had C. hominis IdA14 subtype DNA, while multi locus sequence typing 
(MLST) analysis on a subset (n = 14) of C. hominis samples identified three IdA15G1 samples with a 6 bp insertion 
at the end of the trinucleotide repeat region of the cp47 gene. In 2020, 88.0% (73/83) of samples typed were caused 
by the relatively rare C. hominis subtype IbA12G3. Four mixed infections were observed by NGS with 
three IdA15G1/ IdA14 mixtures and one C. parvum IIaA18G3R1 sample mixed with IIaA16G3R1. No genetic diversity 
using MLST was detected. Epidemiological and molecular data indicates that the outbreaks in 2019 and  2020 were 
each potentially from swimming pool point sources and a new C. hominis subtype IbA12G3  is emerging in Australia. 
The findings of the present study are important for understanding the introduction and transmission of rare 





The Global Enteric Multicenter Study (GEMS), which was conducted in the 
first decade of the millennium, identified Cryptosporidium as a major cause 
of moderate to severe diarrhoea and increased risk of death in children 
under 5-year-olds in developing countries (Kotloff et al., 2013; Levine et al., 
2020). The parasite is also the leading cause of recreational water associated 
gastroenteritis outbreaks worldwide (Efstratiou et al., 2017; Hlavsa et al., 
2017; Ryan et al., 2017). This is largely due to the resistance of the 
environmental stage of the parasite, the oocyst, to normal chlorine levels 
used for pool disinfection and its very low infectious dose (1–125 oocysts) 
(Murphy et al., 2015; Ryan 
et al., 2017). Cryptosporidium may be introduced into swimming pools by 
both symptomatic or asymptomatic bathers, mainly via poor swim- mer 
hygiene (Yoder et al., 2010). 
Among the 44 recognised Cryptosporidium species, C. hominis and 
C. parvum are the main species infecting humans (Jezkova et al., 2020), but 
more than 20 other Cryptosporidium species and genotypes have been 
identified in humans (Xiao and Feng, 2017). Subtyping of Cryptospo- ridium 
is most commonly conducted using sequence analysis of the hy- pervariable 
glycoprotein 60 (gp60) locus (Xiao and Feng, 2017), with the 
C. hominis IbA10G2 subtype, one of the most commonly reported sub- types 
in both sporadic cases and outbreaks worldwide (Chalmers et al., 2010; Ng 
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In Australia, cryptosporidiosis is a nationally notifiable disease. Be- tween 
2001 and 2007, contamination of swimming pools with Crypto- sporidium 
spp. was linked with almost all (41/42) reported outbreaks of recreational 
water associated gastroenteritis (Dale et al., 2010). Between 2013 and 2017 
in Victoria, Australia, 70 outbreaks of cryptosporidiosis were associated 
with aquatic facilities, with 421 confirmed cases (Cullinan et al., 2020). 
Relatively few molecular typing studies have been conducted on swimming 
pool associated outbreaks worldwide and very few in Australia but C. 
hominis IbA10G2 subtype has been linked to cryptosporidiosis outbreaks in 
Western Australia (Ng-Hublin et al., 2015) and Sydney (Mayne et al., 2011; 
Waldron et al., 2011). 
In the January to March period of 2019, 59 cases of cryptosporidiosis were 
reported to the Western Australian Notifiable Infectious Disease Database 
(WANIDD), while 400 cases were notified in the same period in 2020. A 
subset of these cases were investigated using both contact tracing and a 
combination of molecular tools including (1) Sanger sequencing of 18S 
ribosomal DNA and gp60 amplicons to identify spe- cies and subtype, (2) 
next generation sequencing (NGS) at the gp60 locus to identify mixed 
infections and (3) multi locus sequence typing (MLST) analysis to determine 
if any geographic substructure was present. 
2. Materials and methods 
2.1. Sample collection, storage and initial contact tracing 
Faecal samples were collected as a subset of the total number of cases 
reported to WANIDD in WA in 2019 (n 59) and 2020 (n 400). Overall, 
101 Cryptosporidium-positive human faecal samples submitted to three 
local clinical pathology laboratories between February and April 2019 (18 
samples) and January and April 2020 (83 samples) in WA were analysed. 
The presence of Cryptosporidium in faecal samples was initially confirmed 
by microscopy using a modified Ziehl-Neelsen stain microscopy (n 48) in one 
pathology laboratory and using the BD Max Enteric Parasite Real-time PCR 
panel Assay (n 35) and Roche TIB 
Molbiol faecal multiplex PCR (n      18) at the other two pathology cen- tres. 
Upon collection, the samples were stored at 4 ◦C prior to DNA extraction and 
subsequent molecular analysis. 
All cases were cross-referenced with WANIDD to determine the age, gender 
and public health unit (PHU) and were confirmed to be distinct (not 
replicates). Public Health Units in WA are divided into Metropolitan (North 
Metropolitan, South Metropolitan, East Metropolitan) and country public 
health regions (Kimberley, Pilbara, Goldfields, Midwest, Wheatbelt, 
Southwest, Great Southern). Thirty-six and 143 of the total cases reported in 
WANIDD in 2019 and 2020 respectively, were con- tacted by Local 
Governments Environmental Health Officers and/or a WA Department of 
Health epidemiologist by telephone after the initial cryptosporidiosis 
diagnosis to assist with investigations and determine the point source of the 
infections in 2019 and 2020 respectively. A Cryptosporidium case 
questionnaire was administered via the WA Department of Health staff. It is 
designed to gather exposure and other epidemiological information from 
when there are three or more cases in a postcode (with specimen dates 
within a two-week period). It comprises questions related to travel, contact, 
swimming and animal or other environmental exposures. 
2.2. DNA extraction and PCR amplification 
Total genomic DNA was extracted from all faecal samples (~250 mg) 
obtained in 2019 (n 18) and 2020 (n  83) using a DNeasy PowerSoil Kit 
(QIAGEN, Germany) with modifications as previously described (Ng- 
Hublin et al., 2013) and stored at     20 ◦C until analysis. The extracted 
DNA samples were initially characterised using a nested PCR targeting 
the 18S rRNA (18S) locus (Xiao et al., 2001). Samples that were iden- tified 
as C. hominis or C. parvum at the 18S locus were subsequently subtyped using 
a nested PCR at the gp60 locus as previously described (Sulaiman et al., 
2005). Cryptosporidium meleagridis (Stensvold et al., 
2014) and C. fayeri (Power et al., 2009) were typed using separate gp60 
specific subtyping primer pairs, respectively. 
 
2.3 Sanger sequence analysis 
Amplified DNA fragments of all 101 samples were separated by gel 
electrophoresis and purified using an in-house filter tip method as pre- 
viously described (Yang et al., 2013). The purified DNA isolates were 
sequenced in both directions using an ABI Prism™ Dye Terminator Cycle 
Sequencing kit (Applied Biosystems, Foster City, California) according to 
the manufacturer’s instructions. The 18S and gp60 nucleotide se- quences 
identified in the present study were deposited in GenBank under the 
accession numbers (MT928776-MT928784) and (MT952947- MT952955), 
respectively. 
2.4 Next generation amplicon sequencing (NGS) and bioinformatics analysis 
All 101 samples subtyped by Sanger sequencing were included in the NGS 
analysis. Next generation sequencing was conducted by amplifying a 
partial fragment of Cryptosporidium gp60 locus on a Illumina MiSeq 
platform as previously described (Zahedi et al., 2017) and as per stan- 
dard protocols for the MiSeq platform (Illumina Demonstrated Protocol: 
Metagenomic Sequencing Library Preparation). No-template PCR con- trols 
(NTC) and extraction reagent blanks were included in all reactions. 
Libraries were sequenced on an Illumina MiSeq™ using v3 chemistry (2 
300 paired end). Bioinformatic analysis of amplicon sequences was 
performed as previously described (Zahedi et al., 2017). 
 
2.5 Multi locus sequence typing (MLST) 
A subset (n 38) of the two predominant C. hominis subtypes identified 
(IbA12G3 and IdA15G1) were selected for multi locus sequence typing 
(MLST) analysis at five polymorphic markers targeting genes encoding a 47 
kDa protein (cp47), a hydroxyproline-rich glyco- protein (dz-hrgp), a serine 
repeat antigen (msc6–7), and a mucin-like protein gene (mucin1) (Gatei et 
al., 2006; Gatei et al., 2007). The sub- set of samples were randomly 
selected to represent all PHUs from which positives were identified; from 
the 2019 cases, a total of 14 IdA15G1 
subtype cases from the Kimberley (n = 8), Pilbara (n = 5), and Goldfields (n 
= 1) PHU’s were analysed, while 24 IbA12G3 representative samples from 
the 2020 outbreak from North Metropolitan (n = 5), South Metropolitan (n 
= 5), East Metropolitan (n = 5), Pilbara (n = 5), Mid- west (n = 2), and the 
Wheatbelt (n = 2) PHU were analysed. PCR re- actions were conducted in 
25 μl volumes, using 1 μl of extracted DNA in 
the primary PCR, and 1 μl in the secondary PCR and conditions as pre- 
viously described (Mallon et al., 2003; Tanriverdi et al., 2003; Tanri- 
verdi et al., 2006). Amplicons were sequenced by Sanger sequencing in 
both directions as described above. The MLST loci were analysed, 
trimmed and concatenated using Geneious® 10.2.6 (Kearse et al., 2012), and 
aligned with reference sequences from GenBank using ClustalW 
(http://www.clustalw.genome.jp). 
3. Results 
3.1 Epidemiology and links to aquatic centres 
Among the samples collected in 2019 (n 18), most samples origi- nated from 
the country PHUs, the Kimberley (n 12), Pilbara (n 2), Goldfields (n 1) and 
Midwest (n 1). Two cases were acquired overseas (Nepal and Indonesia) 
by residents living in the North and East Perth metropolitan PHUs (Table 1). 
Of the 18 cases from 2019, six were female and 12 were male and the cases 
ranged in age from less than 1 to 55 years of age (data not shown). In 
2019, 12 of the 18 typed cases resided in the same postcode, four were 
interviewed by Local Govern- ment Environmental Health Officers (EHOs) 






Cryptosporidium spp. and subtypes identified by Sanger sequencing and NGS in the 2019 and 2020 outbreaks per individual public health unit (PHU) in WA. 
Public Health Unit (PHU) 
 Year  Species Subtype  NMET SMET EMET KIMB PILB MIDW CENT GOLD OS  Total  
 2019  C. hominis IaA17R3  – – – – – – – – 1  1 (5.5%)  
    IbA10G2  – – – – – – – – 1  1 (5.5%)  
IdA15G1 – – – b12 2 1 – 1 – 16 (89.0%) 
aIdA14 a2 a2 a1 
Total – – – 12 2 1 – 1 2 18 (100.0%) 
2020 C. hominis IbA12G3 c37 13 12 – 7 2 2 – – 73 (88.0%) 
IbA9G3 – 2 – – – – – – – 2 (2.4%) 
aIdA14 a3 
IdA15G1 – – – – 3 – – – – 3 (3.6%) 
IeA12G3T3 1 – – – – – – – – 1 (1.2%) 
C. parvum IIaA18G3R1 – – – – – – – – 1 1 (1.2%) 
aIIaA16G3R1 a1 
C. meleagridis IIIbA23G4R1 2 – – – – – – – – 2 (2.4%) 
C. fayeri IVbA10G1T1R1 – – 1 – – – – – – 1 (1.2%) 
Total 40 15 13 0 10 2 2 0 1 83 (100.0%) 
NMET (North Metropolitan), SMET (South Metropolitan), EMET (East Metropolitan), KIM (Kimberley), PILB (Pilbara), MIDW (Midwest), CENT (Wheatbelt), GOLD 
(Goldfields), OS (infection acquired overseas). 
a  Co-infections with IdA15G1 detected by NGS but not Sanger sequencing. 
b Cases were all from the same Postcode. 
c Five subtyped cases linked to three separate swimming pools outbreaks. 
 
same aquatic centre in the Kimberley region. All cases developed symptoms 
after swimming. Two siblings from the Pilbara were diag- nosed, while one 
case each was reported from the Midwest and Gold- fields PHUs (Table 1). 
In 2020 nearly half of all samples came from reported cases within the 
North Metropolitan PHU (see Table 1 for details). One case was a German 
visitor. Of the 83 typed cases, 47 were female and 36 were male and the cases 
ranged in age from less than 1 to 73 years of age (data not shown). 
Interviews of 143 notified cases from the first quarter of 2020 by either 
Local Government EHOs or OzFoodNet staff identified nine point-source 
outbreaks at recreational aquatic centres. From 2020, among those 143 
interviewed, only 16 had genotyping results; five of the cases subtyped 
were associated with three separate outbreaks, which were all in the North 
Metropolitan region (Table 1). 
3.2 Cryptosporidium species and subtypes identified by sanger sequencing 
All the 101 faecal samples were successfully analysed by Sanger 
sequencing of the gp60 locus. In 2019, three C. hominis subtypes were 
identified; IdA15G1–89.0% (16/18), IaA17R3–5.5% (1/18), and 
IbA10G2–5.5% (1/18). In 2020, a total of 83 samples representing four 
Cryptosporidium spp. and seven subtypes were identified: C. hominis 
IbA12G3 subtype - 88.0% (73/83), IbA9G3–2.4% (2/83), IdA15G1–3.6% 
(3/83), IeA12G3T3–1.2% (1/83), C. parvum IIaA18G3R1–1.2% (1/83), C. 
fayeri IVbA10G1T1R1–1.2% (1/83), a 
C. meleagridis IIIgA23G4R1 subtype variant - 2.4% (2/83) (Table 1). 
Sequence alignment analysis with reference C. meleagridis sequences 
from GenBank revealed that the IIIgA23G4R1 subtype variant identified in 
the present study exhibited 99.3% similarity to C. meleagridis III- 
gA25G3R1 subtype samples from two chickens from a market in Brazil 
(da Cunha et al., 2018). 
3.3 Next generation sequencing (NGS) 
Amplicon NGS identified mixed Cryptosporidium infections in 5/ 16C. 
hominis IdA15G1 subtypes from 2019 and in all three C. hominis IdA15G1 
subtypes detected in 2020. In all eight cases, co-infections with 
C. hominis IdA14 subtype were identified. All mixed C. hominis IdA14 
cases were only reported from the Pilbara (2 cases each in 2019 and 
2020), Goldfields (1 case) and the Kimberly (2 out of 12C. hominis 
IdA15G1 cases) in 2019. The single sample positive for C. parvum 
IIaA18G3R1  subtype  identified  in  2020,  had  a  co-infection  with 
C. parvum subtype IIaA16G3R1 (1.2%). Overall, in 2019, approximately 28% 
(5/18) of the samples typed had mixed infections, compared to 
~5% (4/83) for 2020 (Table 1). 
3.4 Multi locus sequencing 
 
Multi locus sequence typing was carried out on a subset (n = 38) of total 
samples; all C. hominis IdA15G1 (n = 19) and a subset IbA12G3 (n 
= 19) from 2019 and 2020 at the cp47 (387 bp), dz-hrgp (456 bp), gp60 
(828 bp), msc6–7 (465 bp), and mucin1 (777 bp) genes to produce a 2913 
bp MLST fragment of concatenated sequences. One C. hominis IdA15G1 
sample from 2019 and 2 samples from 2020 had a 6 bp nucleotide (ATGATA) 
insertion at the cp47 gene. Representative se- quences of cp47, dz-hrgp, 
msc6–7, gp60 and mucin1 loci obtained in the present study were deposited 
in GenBank under Accession numbers MW855868-MW855877. 
4. Discussion 
The present study combined conventional epidemiological tracing and 
molecular analyses to examine a subset of cases reported to the WANIDD in 
WA in 2019 and 2020. In the first quarter of 2019, 59 cases of 
cryptosporidiosis were reported in WA and of the ~30% (18/59) of cases 
that were genotyped, C. hominis IdA15G1 was identified in 16/18 WA 
acquired cases. The remaining two cryptosporidiosis infections ac- quired 
by WA residents whilst overseas in Indonesia and Nepal, were identified as 
C. hominis IbA10G2 and 1aA17R3, respectively. Subtype IaA17 is a rare 
subtype that has previously been reported in children in rural Ghana 
(Eibach et al., 2015). Subtype IdA14 is also rare and has been reported 
in a pediatric hospital in China (Feng et al., 2012). Sub- type IbA10G2 is one 
of the major subtypes reported in sporadic and outbreak cases worldwide 
including Australia (Ng et al., 2010a), but has not been reported in any 
subtyping in WA since 2018 (Braima et al., 2019). 
The C. hominis IdA15G1 subtype has previously been reported as the 
dominant subtype infecting Aboriginal people in WA (Ng-Hublin et al., 
2018). Consistent with this, all the IdA15G1 subtype cases detected in 
2019 were from country regions (n = 16), where Aboriginal people 
comprise 30–40% of the population, in comparison to just 1.5% of the 
metropolitan WA population (Ng-Hublin et al., 2017). Of the 18 typed 
samples from 2019, amplicon NGS identified mixed infections (with 








polymerase slippage in the mixed infections cannot be completely ruled out. 
However strict laboratory and bioinformatic processes (Elbrecht et al., 
2018) were implemented in the present study including; primer design 
(without degenerate bases), use of high fidelity Taq and removal of low 
abundant and chimeric sequences as outlined in Zahedi et al. (2017). 
There was also a lack of mixed IdA15G1 infections observed in the 
remaining C. hominis (83.3%) from the Kimberly. Therefore, it is most 
likely that C. hominis sequences identified in the present study represent 
true biological sequences. 
Multi locus sequence typing identified a 6 bp insertion in the mi- crosatellite 
repeat region of the cp47 gene in one of the IdA15G1 subtype samples from 
2019 but no other sequence variation was detected. Contact tracing 
identified two cases linked to the same swimming pool in the Kimberley. A 
previous study reported a cryptosporidiosis outbreak in the Kimberley 
region in 2012, with 18 notified cases of cryptosporidiosis linked to a 
swimming pool in Broome, WA (Ng-Hublin et al., 2015). In that study, C. 
hominis IbA10G2 subtype was detected in all eight human samples that were 
typed and in one water sample (Ng- Hublin et al., 2015) and the outbreak 
was linked to an individual returning from India with gastroenteritis who 
continued to swim at the pool against their doctor’s advice. 
In the first quarter of 2020, 400 cryptosporidiosis cases were re- ported and 
of the ~21% (83/400) of cases that were typed, C. hominis IbA12G3 emerged 
as the predominant subtype, responsible for nearly 88.0% (73/83) of typed 
cases from that quarter. Until recently, 
C. hominis IbA12G3 was a rare subtype and was first reported in a single 
human case from the United Kingdom in 2010 (Pangasa et al., 2010) and 
then in sporadic cases in South Africa (Samra et al., 2016), Mexico (Urrea-
Quezada et al., 2018), the United Kingdom (Chalmers et al., 2019),  Spain  
(Millán  et  al.,  2019)  and  most  recently  in  four  cases  in Southern Ireland 
(O’Leary et al., 2020). Sequence comparisons of gp60 amplicons showed 
100% sequence similarity between the IbA12G3 positives in the present 
study with the previously reported human cases. In one IbA12G3 subtype 
identified, the order of the trinucleotide repeats was different, but the 
number of TCA and TCG repeats was the same (i.e. they still added up to 12 
TCA and 3 TCG repeats) and this variant has been reported in non-human 
primates, Rhesus macaques (Macaca mulatta) in China (Karim et al., 2014). 
In 2017, IbA12G3 was linked with a swimming pool outbreak in the United 
Kingdom involving four confirmed cases (Chalmers et al., 2019). In the 
present study, five IbA12G3 subtype cases (2, 2 and one case) from the large 
community outbreak in 2020 were each linked to three separate swimming 
pool point source outbreaks at recreational aquatic centres in the North 
Metropolitan area. An additional five swimming pool point source out- 
breaks involving other cases that were not typed were also identified. 
This is the first report of the C. hominis IbA12G3 subtype in Australia. Based 
on dates, interviews and subtyping data, it seems possible that the first 
aquatic centre outbreak, which was at a very large centre and included two 
cases subtyped in the present study, may have been the main source, which 
then spread to the community and other aquatic centres. Next Generation 
Sequencing of the IbA12G3 isolates showed no mixed infections with C. 
hominis, C. parvum and C. cuniculus gp60 sub- types and MLST analysis on a 
subset of these samples revealed no genetic diversity, suggesting that the 
same parasite population was responsible for the outbreak cases. Due to 
COVID-19, strict social distancing mea- sures were implemented throughout 
WA in March 2020, which included the closure of all aquatic facilities on the 
26th of March 2020. This resulted in a marked reduction in cases, effectively 
ending the outbreak, with levels returning close to baseline by the end of 
April 2020. 
Interestingly, from 2002 until early 2017 in WA, C. hominis subtype 
IbA10G2 dominated in non-Aboriginal people (Ng et al., 2010a, 2010b; 
Ng-Hublin et al., 2017; Braima et al., 2019), but in 2017, the previously 
rare C. hominis subtype IfA12G1R5 emerged as the dominant subtype 
(Braima et al., 2019). This subtype (IfA12G1R5) had previously become the 
dominant C. hominis subtype in the US in 2013 and was associated with 
swimming pool outbreaks in Alabama and Arizona (Hlavsa et al., 
2017). The reason for the emergence of the rare subtypes IfA12G1R5 in 2017 
and IbA12G3 in 2020 in WA is unknown, but in the USA the swift emergence 
and transmission of a virulent subtype (IaA28R4) in 2008 was linked to 
dispersal through swimming pools (Feng et al., 2014). It may also be due to 
the increasingly heterogeneous population in metropolitan areas and the 
transmission of travel acquired subtypes (Chalmers et al., 2008; Insulander 
et al., 2013). The C. hominis IbA9G3 positives in the present study were from 
a 4-year-old male infant and a 37-year-old male, and the single C. hominis 
IeA12G3T3 subtype was from a 13-year-old male with a Salmonella co-
infection; both are rela- tively rare subtypes (Ng et al., 2010b; Waldron et al., 
2011; Wang et al., 2013). Subtype IdA19 was linked with a waterpark-
associated outbreak in Ohio, USA in 2016 (Hlavsa et al., 2017). 
Among the samples analysed in 2020, three mixed IdA15G1/1dA14 
infections were identified from remote PHUs and one mixed C. parvum 
IIaA18G3R1/ IIaA16G3R1 co-infection was identified in a female visitor 
from Germany. This is the first report of a novel C. meleagridis III- gA23G4R1 
variant in two cases, which appear to be unrelated, as both cases were not 
from the same household and the specimen dates were almost two months 
apart. One of the patients attended a hospital with symptoms of diarrhoea 
and bloating and had no travel history or ill contacts, suggesting the infection 
may have been acquired locally. Cryptosporidium fayeri (subtype 
IVbA10G1T1R1) identified in a 37-year- old immunosuppressed female in 
the present study, is only the second report of a C. fayeri infection in a human 
host and has been discussed in more detail in Braima et al. (2021). 
The 2020 outbreak was much larger (a rate of 16.2 per 100,000 population 
for the first two quarters) compared to 2019 (annual rate of 
7.4 per 100,000 population). In 2019, cases were predominantly in remote 
communities, whereas the 2020 outbreak occurred in metro- politan Perth. 
Molecular analyses also revealed the strikingly different genomic 
epidemiology between the 2019 and 2020 cases, with the small increase in 
2019 cases infected with rural and remote Aboriginal- population associated 
C. hominis IdA15G1 subtype and the large outbreak in 2020 associated with 
the previously rare C. hominis IbA12G3 subtype. 
To date, four studies have conducted amplicon gp60 NGS of Crypto- 
sporidium-positive faecal samples in an attempt to identify low- 
abundance intra-isolate variants (Grinberg et al., 2013; Zahedi et al., 2017; 
DeMone et al., 2020; Mphephu et al., 2021). In the study by Grinberg et al. 
(2013), NGS analysis of two C. parvum samples from New Zealand 
identified a total of ten gp60 subtypes, compared with two gp60 subtypes 
by Sanger sequencing. In the study by Zahedi et al. (2017), gp60 amplicon 
NGS of animal-derived C. hominis (n 11), C. parvum (n 
22) and C. cuniculus (n 8) samples from Australia and China iden- 
tified additional subtypes in individual C. parvum and C. cuniculus 
samples (n      2–4 subtypes), but not in C. hominis (compared to the single 
subtypes identified by Sanger sequencing in all samples). More recently, 
DeMone et al. (2020) developed an 18S NGS amplicon assay designed to 
detect Cryptosporidium spp. and other protozoa in shellfish as a tool for 
monitoring protozoan contamination in food and water. In addition, NGS 
of 18S and gp60 amplicons was used to identify Cryptosporidium 
species (C. parvum, C. hominis, C. cuniculus, C. meleagridis and C. wrairi) 
and subtypes (n 92 corresponding to 22 subtype families) from river 
water and riverbed sediment from the Apies River in South Africa 
(Mphephu et al., 2021). 
In the present study, the lack of intra-isolate subtype diversity in 
C. hominis IbA12G3 cases suggests the recent introduction of this sub- type 
into the WA population. The lack of diversity was also confirmed by MLST 
analyses which may be interpreted as further evidence for its recent 
population expansion in WA and potentially clonal population structure. 
However, further analysis is required to understand the pop- ulation 
dynamics and substructure of IbA12G3 in WA. In previous studies, MLST 
analyses at eight loci was used to characterise the emer- gence of C. hominis 
IaA28R4 as a cause of sporadic and outbreak-related cases in the US and at 





States were identified (Feng et al., 2014). A more extensive study using 32 
MLST markers identified a largely clonal population structure for 
C. hominis IbA10G2 human samples from Peru, which is consistent with 
most previous population studies on C. hominis (Kvac et al., 2013). 
The findings in the present study have been useful for understanding the 
transmission of Cryptosporidium in WA. The 2019 and 2020 out- breaks 
were clearly unrelated as they were caused by different C. hominis subtypes 
and both amplicon NGS and MLST analysis support the recent introduction 
of C. hominis IbA12G3 into the WA population. Some of the limitations of this 
study include; the cases subtyped represent only a subset of the WA 
population. Furthermore, only limited contact tracing was conducted on the 
typed cases to implicate aquatic centres in the outbreaks. A larger sampling 
size, involving more genotyping analysis and contact tracing would provide 
a clearer representation of crypto- sporidiosis in the WA human population. 
Routine typing of Cryptospo- ridium using molecular methods is of public 
health importance. The identification of cryptosporidiosis outbreaks 
specifically linked to swimming pools warrants a more detailed examination 
of swimming pool filter backwash samples and the knowledge, attitudes and 
practices of swimming pool patrons to better understand recreational water 
associated transmission dynamics. 
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